http://www.cardiobrief.org/2014/03/25/glucose-measurements-dont-improve-cardiovascular-risk-assessment/2014-03-25T16:27:27-04:00http://www.cardiobrief.org/2014/03/27/fda-advisory-panel-recommends-against-approval-of-novartis-heart-failure-drug/2014-03-27T16:35:37-04:00http://www.cardiobrief.org/2014/03/28/guest-post-how-sure-can-we-be-about-optisure/2014-03-28T07:55:01-04:00http://www.cardiobrief.org/2014/03/28/new-atrial-fibrillation-guideline-supports-new-drugs-and-devices/2014-03-28T16:20:15-04:00http://www.cardiobrief.org/2014/03/29/no-benefit-found-in-first-real-test-of-renal-denervation/2016-01-12T12:14:55-05:00http://www.cardiobrief.org/2014/03/29/survival-advantage-for-tavr-over-surgery-in-high-risk-patients/2014-03-29T08:28:04-04:00http://www.cardiobrief.org/2014/03/30/first-tavr-comparison-trial-favors-sapien-xt-over-corevalve/2014-03-30T08:22:28-04:00http://www.cardiobrief.org/2014/03/30/madit-crt-long-term-follow-up-shows-survival-benefit-with-crt-d/2014-03-30T11:32:15-04:00http://www.cardiobrief.org/2014/03/30/high-sensitivity-troponin-test-could-identify-low-risk-chest-pain-patients-in-the-ed/2014-03-30T15:53:05-04:00http://www.cardiobrief.org/2014/03/31/early-success-for-novel-novartis-heart-failure-drug/2014-03-31T09:42:10-04:00http://www.cardiobrief.org/2014/03/31/aspirin-and-clonidine-fail-to-help-surgery-patients/2014-03-31T10:08:45-04:00http://www.cardiobrief.org/2014/03/31/novartis-trial-was-stopped-early-because-of-a-significant-drop-in-cardiovascular-mortality/2014-03-31T15:05:58-04:00http://www.cardiobrief.org/2014/04/01/a-new-novartis-heart-failure-drug-might-be-a-blockbuster/2015-09-15T19:48:30-04:00http://www.cardiobrief.org/2014/04/03/cardiovascular-disease-declines-in-rich-countries-but-grows-elsewhere/2014-04-03T18:56:08-04:00http://www.cardiobrief.org/2014/04/07/boehringer-ingelheims-pradaxa-gains-new-indication/2014-04-07T12:11:39-04:00http://www.cardiobrief.org/2014/04/08/study-suggests-link-between-viagra-and-melanoma/2014-04-08T12:33:46-04:00http://www.cardiobrief.org/2014/04/08/circulation-retracts-paper-by-stem-cell-pioneer-and-its-own-editor/2014-04-08T23:22:57-04:00http://www.cardiobrief.org/2014/04/09/troubled-nhlbi-topcat-trial-disappoints/2014-04-09T17:15:31-04:00http://www.cardiobrief.org/2014/04/10/cardiology-and-the-medicare-data-avalanche/2014-04-10T14:13:29-04:00http://www.cardiobrief.org/2014/04/11/lancet-editors-raises-more-questions-about-prominent-harvard-stem-cell-researcher/2014-04-11T10:48:39-04:00http://www.cardiobrief.org/2014/04/14/the-uncertain-future-of-a-once-highly-promising-device-for-lowering-blood-pressure/2015-09-15T19:50:23-04:00http://www.cardiobrief.org/2014/04/15/new-medtronic-heart-valve-threatened-by-court-decision/2014-04-15T13:13:59-04:00http://www.cardiobrief.org/2014/04/17/fda-grants-fast-track-status-to-amgen-heart-failure-drug/2014-04-17T17:09:20-04:00http://www.cardiobrief.org/2014/04/21/will-edwards-snatch-defeat-from-the-jaws-of-its-victory-over-medtronic/2014-04-21T08:45:48-04:00http://www.cardiobrief.org/2014/04/22/new-study-lends-support-for-alternative-heart-attack-treatment-strategy/2014-04-22T17:06:47-04:00http://www.cardiobrief.org/2014/04/27/what-role-should-coca-cola-play-in-obesity-research/2015-09-15T19:50:04-04:00http://www.cardiobrief.org/2014/04/28/stem-cell-therapy-to-fix-the-heart-a-house-of-cards-about-to-fall/2015-09-15T19:49:41-04:00http://www.cardiobrief.org/2014/04/30/another-failed-hdl-therapy-trial/2014-04-30T18:18:20-04:00http://www.cardiobrief.org/2014/05/05/fda-comes-out-against-aspirin-to-prevent-first-heart-attacks/2014-05-05T12:48:31-04:00http://www.cardiobrief.org/2014/05/06/fda-approves-new-omega-3-supplement/2014-05-06T12:49:08-04:00http://www.cardiobrief.org/2014/05/08/fda-approves-novel-merck-drug-to-prevent-heart-attacks-and-strokes/2014-05-08T17:21:40-04:00http://www.cardiobrief.org/2014/05/09/routine-shock-testing-not-required-during-icd-implantation/2014-05-09T10:25:52-04:00http://www.cardiobrief.org/2014/05/12/intensive-insulin-therapy-saves-lives-but-is-the-finding-still-relevant/2014-05-12T18:44:03-04:00http://www.cardiobrief.org/2014/05/13/strike-2-for-once-promising-gsk-stinkbomb-heart-drug/2014-05-13T12:00:27-04:00http://www.cardiobrief.org/2014/05/13/fda-study-provides-some-reassurance-about-boehringer-ingelheims-pradaxa/2014-05-13T13:55:22-04:00http://www.cardiobrief.org/2014/05/14/bmj-articles-critical-of-statins-provoke-kerfuffle/2014-05-14T19:06:43-04:00http://www.cardiobrief.org/2014/05/15/exercise-can-there-be-too-much-of-a-good-thing/2014-05-15T15:41:15-04:00http://www.cardiobrief.org/2014/05/16/fda-rejects-novel-novartis-drug-for-acute-heart-failure/2014-05-16T10:33:51-04:00http://www.cardiobrief.org/2014/05/18/disappointing-results-for-statins-in-two-nih-trials/2014-05-18T15:13:25-04:00http://www.cardiobrief.org/2014/05/19/bmj-names-panel-members-to-review-disputed-statin-articles/2014-05-19T16:07:29-04:00http://www.cardiobrief.org/2014/05/19/hospitalizations-for-atrial-fibrillation-are-on-the-rise/2014-05-19T16:31:49-04:00http://www.cardiobrief.org/2014/05/20/medtronic-to-pay-over-1billion-to-settle-patent-litigation-with-edwards-lifesciences/2014-05-20T12:37:59-04:00http://www.cardiobrief.org/2014/05/21/the-walking-dead-renal-denervation-in-europe-just-cant-be-stopped/2015-09-15T19:51:35-04:00http://www.cardiobrief.org/2014/05/28/boehringer-ingelheim-settles-us-pradaxa-litigation-for-650-million/2014-05-28T10:14:29-04:00http://www.cardiobrief.org/2014/05/28/fda-approves-novel-implanted-sensor-to-monitor-heart-failure/2014-05-28T13:55:58-04:00http://www.cardiobrief.org/2014/05/28/prescription-delay-following-stent-implantation-is-a-common-and-deadly-problem/2014-05-31T14:34:54-04:00http://www.cardiobrief.org/2014/05/29/portrait-of-the-global-obesity-pandemic/2014-05-29T10:26:34-04:00http://www.cardiobrief.org/2014/05/30/large-study-uncovers-new-details-about-the-role-of-hypertension-in-cvd/2014-05-30T10:01:07-04:00http://www.cardiobrief.org/2014/06/03/prophylactic-icds-appear-effective-in-less-severe-hf-patients/2014-06-03T16:27:46-04:00http://www.cardiobrief.org/2014/06/05/air-pollution-and-cardiovascular-disease-its-complicated/2014-06-05T11:04:54-04:00http://www.cardiobrief.org/2014/06/09/wide-range-in-cancer-risk-from-radiation-in-children-undergoing-heart-surgery/2014-06-09T17:03:27-04:00http://www.cardiobrief.org/2014/06/10/major-medical-organizations-establish-ambitious-diabetes-registry/2014-06-10T19:13:38-04:00http://www.cardiobrief.org/2014/06/12/sharp-scrutiny-from-european-medicines-agency-of-amgen-and-servier-heart-drug/2014-06-12T14:18:13-04:00http://www.cardiobrief.org/2014/06/12/medtronics-corevalve-gains-new-indication-for-high-risk-patients/2014-06-12T18:49:11-04:00http://www.cardiobrief.org/2014/06/13/fda-advisory-panel-supports-novel-drug-coated-balloon/2014-06-13T10:14:02-04:00http://www.cardiobrief.org/2014/06/15/positive-results-for-new-oral-drug-from-actelion/2014-06-15T21:41:04-04:00http://www.cardiobrief.org/2014/06/16/european-regulators-investigate-cardiovascular-safety-of-ibuprofen/2014-06-16T11:08:18-04:00http://www.cardiobrief.org/2014/06/16/fda-approves-second-generation-heart-valve-from-edwards-lifesciences/2014-06-16T18:32:09-04:00http://www.cardiobrief.org/2014/06/17/mixed-results-for-thrombolysis-in-pulmonary-embolism/2014-06-17T19:20:13-04:00http://www.cardiobrief.org/2014/06/17/yet-another-delay-for-boston-scientifics-watchman-device/2014-06-17T20:28:54-04:00http://www.cardiobrief.org/2014/06/19/large-genetic-studies-may-help-unravel-the-triglyceride-problem/2014-06-19T13:32:01-04:00http://www.cardiobrief.org/2014/06/23/mobile-cardiovascular-screening-programs-come-under-fire/2014-06-23T19:36:10-04:00http://www.cardiobrief.org/2014/06/23/if-you-snus-you-lose-study-shows-benefits-of-quitting-smokeless-tobacco/2014-06-23T16:49:07-04:00http://www.cardiobrief.org/2014/06/24/fda-recalls-another-batch-of-generic-metoprolol/2014-06-24T13:04:38-04:00http://www.cardiobrief.org/2014/06/24/in-emerging-china-heart-attacks-skyrocket-but-treatment-lags/2014-06-24T16:55:40-04:00http://www.cardiobrief.org/2014/06/24/fda-ends-olmesartan-safety-review-but/2014-06-24T20:26:40-04:00http://www.cardiobrief.org/2014/07/01/study-offers-reassurance-about-newer-drug-eluting-stents/2014-07-01T11:16:47-04:00http://www.cardiobrief.org/2014/07/01/esc-hot-lines-first-real-data-on-promising-novartis-heart-failure-drug/2014-07-01T17:14:08-04:00http://www.cardiobrief.org/2014/07/02/januvia-linked-to-increase-in-heart-failure-hospitalizations/2014-07-02T17:09:09-04:00http://www.cardiobrief.org/2014/07/03/more-sunshine-cms-wants-companies-to-report-payments-to-physicians-for-medical-education/2014-07-03T18:29:42-04:00http://www.cardiobrief.org/2014/07/06/merck-uses-legal-threats-to-stifle-negative-advice-about-zetia-and-vytorin-in-italy/2014-07-06T15:22:18-04:00http://www.cardiobrief.org/2014/07/07/controversial-trial-finds-no-benefit-for-expensive-medicines-company-drug/2014-07-07T11:23:45-04:00http://www.cardiobrief.org/2014/07/08/study-explores-expanded-use-for-edwards-and-medtronics-new-heart-valves/2014-07-08T22:38:01-04:00http://www.cardiobrief.org/2014/07/10/fda-places-clinical-hold-on-phase-3-trial-of-novel-anticoagulant/2014-07-10T14:40:12-04:00http://www.cardiobrief.org/2014/07/14/fda-once-again-reaches-conclusions-at-odds-with-its-own-staff/2014-07-14T17:30:01-04:00http://www.cardiobrief.org/2014/07/15/cleveland-clinic-once-again-tops-heart-hospital-rankings/2014-07-15T11:55:51-04:00http://www.cardiobrief.org/2014/07/16/new-evidence-fuels-concerns-about-the-safety-of-niacin/2014-07-16T17:04:43-04:00http://www.cardiobrief.org/2014/07/21/probiotics-may-help-reduce-blood-pressure/2014-07-21T16:23:05-04:00http://www.cardiobrief.org/2014/07/22/study-finds-flaws-in-new-treatment-for-blood-clots/2014-07-22T10:38:38-04:00http://www.cardiobrief.org/2014/07/23/more-questions-raised-about-boehringer-ingelheims-pradaxa/2014-07-23T14:23:04-04:00http://www.cardiobrief.org/2014/07/28/running-any-amount-is-good-and-more-may-not-be-better/2014-07-28T15:38:42-04:00http://www.cardiobrief.org/2014/07/28/death-by-running-its-the-heat-and-not-the-heart/2014-07-28T20:54:05-04:00http://www.cardiobrief.org/2014/07/28/hormone-therapy-at-menopause-fails-to-halt-heart-disease-progression/2014-07-28T17:26:07-04:00http://www.cardiobrief.org/2014/07/30/dutch-investigation-finds-serious-flaws-in-influential-new-england-journal-of-medicine-study/2015-09-15T19:53:28-04:00http://www.cardiobrief.org/2014/08/01/guideline-critics-shift-attacks-from-beta-blockers-to-statins/2014-08-01T12:06:03-04:00http://www.cardiobrief.org/2014/08/02/no-retraction-for-you-review-panel-exonerates-medical-journal-in-statin-kerfuffle/2014-08-02T12:26:59-04:00http://www.cardiobrief.org/2014/08/06/clot-busters-for-stroke-gain-more-support/2014-08-06T09:29:17-04:00http://www.cardiobrief.org/2014/08/06/principal-investigator-of-suspended-cytori-stem-cell-trials-remains-hopeful/2014-08-06T12:33:51-04:00http://www.cardiobrief.org/2014/08/08/warning-neck-adjustments-might-lead-to-stroke/2014-08-12T17:00:47-04:00http://www.cardiobrief.org/2014/08/11/study-offers-little-support-for-an-old-drug/2014-08-11T16:37:58-04:00http://www.cardiobrief.org/2014/08/12/improve-it-trial-scheduled-for-presentation-in-november/2014-08-12T12:57:40-04:00http://www.cardiobrief.org/2014/08/12/the-complicated-story-behind-yet-another-disappeared-article-at-a-top-heart-journal/2014-08-12T19:23:33-04:00http://www.cardiobrief.org/2014/08/13/new-studies-fuel-the-debate-over-sodium/2014-08-13T17:36:14-04:00http://www.cardiobrief.org/2014/08/14/an-experts-perspective-why-salt-is-not-like-tobacco-and-why-guidelines-are-tricky/2016-01-21T12:14:47-05:00http://www.cardiobrief.org/2014/08/18/an-old-study-fuels-debate-over-blood-pressure-guidelines/2014-08-18T16:52:04-04:00http://www.cardiobrief.org/2014/08/19/us-department-of-justice-ends-investigation-of-astrazenca-trial/2014-08-19T19:28:20-04:00http://www.cardiobrief.org/2014/08/20/increased-heart-risk-linked-to-popular-antibiotic/2014-08-20T13:40:43-04:00http://www.cardiobrief.org/2014/08/21/fda-grants-new-indication-for-apixaban/2014-08-21T16:48:44-04:00http://www.cardiobrief.org/2014/08/22/why-guidelines-should-be-waged-like-war/2016-01-21T11:31:31-05:00http://www.cardiobrief.org/2014/08/25/rise-in-popularity-of-e-cigarettes-sparks-concerns-and-recommendations/2014-08-25T13:42:41-04:00http://www.cardiobrief.org/2014/08/27/predicting-paradigm-hf-or-what-to-expect-when-youre-expecting/2014-08-27T11:36:49-04:00http://www.cardiobrief.org/2014/08/30/paradigm-hf-establishes-a-new-paradigm-for-heart-failure-treatment/2015-11-24T14:16:25-05:00http://www.cardiobrief.org/2014/08/30/15553/2014-08-30T14:01:24-04:00http://www.cardiobrief.org/2014/08/31/trial-provokes-sound-and-fury-over-controversial-servier-and-amgen-drug/2014-08-31T12:57:58-04:00http://www.cardiobrief.org/2014/08/31/early-hint-at-cardiovascular-outcomes-with-sanofis-and-regenerons-rapidly-advancing-cholesterol-drug/2014-08-31T13:33:05-04:00http://www.cardiobrief.org/2014/09/01/newly-elected-european-society-of-cardiology-president-co-authored-hundreds-of-papers-with-don-poldermans/2015-11-16T09:55:49-05:00http://www.cardiobrief.org/2014/09/02/fractional-flow-reserve-gains-support-in-stable-cad-and-nstemi/2014-09-02T11:22:29-04:00http://www.cardiobrief.org/2014/09/08/beyond-kickbacks-more-questions-about-unnecessary-cardiovascular-tests/2015-09-15T19:54:51-04:00http://www.cardiobrief.org/2014/09/09/statins-and-diabetes-a-clearer-picture-emerges/2014-09-09T18:33:52-04:00http://www.cardiobrief.org/2014/09/10/fda-advisory-panel-offers-cautious-support-for-polypill/2014-09-10T17:38:56-04:00http://www.cardiobrief.org/2014/09/10/fda-approves-new-weight-loss-drug-from-orexigen-and-takeda/2014-09-10T20:01:15-04:00http://www.cardiobrief.org/2014/09/11/japanese-research-scandal-involving-novartis-blood-pressure-drug-widens/2014-09-11T11:52:32-04:00http://www.cardiobrief.org/2014/09/15/acc-and-aha-dont-recommend-routine-ecg-screening-of-young-people/2014-09-15T16:48:30-04:00http://www.cardiobrief.org/2014/09/15/cheaper-generic-statins-beat-brand-name-statins-in-adherence-and-outcomes/2014-09-15T17:38:29-04:00http://www.cardiobrief.org/2014/09/16/amarin-says-it-will-complete-cardiovascular-outcomes-trial-for-its-fish-oil-pill/2017-03-23T11:26:28-04:00http://www.cardiobrief.org/2014/09/18/way-beyond-kickbacks-more-serious-misconduct-alleged-against-medical-testing-company/2015-09-15T19:56:27-04:00http://www.cardiobrief.org/2014/09/18/fda-approves-lillys-once-weekly-shot-for-diabetes/2014-09-18T16:54:00-04:00http://www.cardiobrief.org/2014/09/21/counterintuitive-advice-about-staying-alive-after-a-heart-attack/2014-09-21T12:41:05-04:00http://www.cardiobrief.org/2014/09/22/cardiology-group-withdraws-choosing-wisely-recommendation/2014-09-22T17:34:00-04:00http://www.cardiobrief.org/2014/09/23/a-disappeared-article-finally-published-finds-a-desultory-response-to-scientific-misconduct/2015-09-15T19:56:42-04:00http://www.cardiobrief.org/2014/09/23/embattled-hdl-laboratory-ceo-resigns-amid-federal-investigation/2014-09-23T18:33:40-04:00http://www.cardiobrief.org/2014/09/26/new-england-journal-of-medicine-declines-to-retract-papers-from-disgraced-research-group/2015-09-15T19:56:53-04:00http://www.cardiobrief.org/2014/09/27/why-bad-doctors-are-like-bad-writers-the-curse-of-knowledge/2015-09-15T19:57:25-04:00http://www.cardiobrief.org/2014/09/29/american-heart-association-pay-more-attention-to-radiation-in-imaging-procedures/2014-09-29T17:13:36-04:00http://www.cardiobrief.org/2014/09/30/no-difference-in-survival-found-for-different-aortic-valve-prostheses/2014-09-30T20:00:21-04:00http://www.cardiobrief.org/2014/10/01/study-suggests-vitamin-d-cant-prevent-diabetes/2014-10-01T13:46:33-04:00http://www.cardiobrief.org/2014/10/02/cholesterol-drugs-haunted-by-ghosts-of-past-present-and-future/2014-10-02T15:35:27-04:00http://www.cardiobrief.org/2014/10/06/nissen-urges-prompt-revision-of-cardiovascular-guidelines/2014-10-06T16:22:58-04:00http://www.cardiobrief.org/2014/10/07/novel-boston-scientific-device-headed-for-another-rough-fda-panel/2014-10-07T11:55:31-04:00http://www.cardiobrief.org/2014/10/08/fda-panel-gives-cautious-endorsement-to-novel-boston-scientific-device/2014-10-08T19:23:53-04:00http://www.cardiobrief.org/2014/10/10/first-drug-coated-balloon-approved-by-fda-for-leg-blockages/2014-10-10T15:00:05-04:00http://www.cardiobrief.org/2014/10/13/medicare-reimbursement-for-lung-cancer-screening-provokes-debate/2014-10-13T16:55:20-04:00http://www.cardiobrief.org/2014/10/14/inappropriate-heart-stress-tests-may-waste-half-a-billion-dollars-a-year/2014-10-14T13:05:28-04:00http://www.cardiobrief.org/2014/10/15/another-diet-myth-exploded-gradual-weight-loss-no-better-than-rapid-weight-loss/2014-10-15T18:54:56-04:00http://www.cardiobrief.org/2014/10/17/doctor-youre-going-to-have-a-heart-attack-patient-your-tests-results-are-giving-me-a-heart-attack/2016-02-08T12:38:19-05:00http://www.cardiobrief.org/2014/10/20/cigna-sues-embattled-hdl-laboratory-for-84-million/2014-10-20T13:22:31-04:00http://www.cardiobrief.org/2014/10/21/paper-behind-the-green-coffee-bean-diet-craze-retracted/2014-10-21T12:47:32-04:00http://www.cardiobrief.org/2014/10/26/genetic-study-suggests-possible-causal-role-for-ldl-in-aortic-valve-disease/2014-10-26T15:41:36-04:00http://www.cardiobrief.org/2014/10/27/ebola-natural-cures-and-panic-a-rant/2014-10-27T12:38:25-04:00http://www.cardiobrief.org/2014/10/29/grad-student-invents-flying-ambulance-drone-to-deliver-emergency-shocks/2014-10-29T19:54:19-04:00http://www.cardiobrief.org/2014/10/30/aortic-valve-surgery-for-nonagenarians/2014-10-30T10:57:20-04:00http://www.cardiobrief.org/2014/10/31/fda-advisory-panel-gives-tepid-support-to-new-daiichi-sankyo-drug/2014-10-31T12:28:59-04:00http://www.cardiobrief.org/2014/11/03/economic-study-finds-vte-prophylaxis-with-low-molecular-weight-heparin-cost-effective/2014-11-03T10:51:51-05:00http://www.cardiobrief.org/2014/11/04/af-patients-at-increased-risk-for-silent-strokes/2014-11-04T09:41:08-05:00http://www.cardiobrief.org/2014/11/05/nonobstructive-coronary-artery-disease-linked-to-elevated-risk/2014-11-05T13:19:11-05:00http://www.cardiobrief.org/2014/11/07/what-you-need-to-know-about-improve-it/2014-11-07T08:38:40-05:00http://www.cardiobrief.org/2014/11/12/popular-diets-achieve-only-modest-long-term-weight-loss/2014-11-12T08:26:12-05:00http://www.cardiobrief.org/2014/11/13/newly-identified-mutations-act-like-a-lifetime-of-treatment-with-ezetimibe/2014-11-13T10:17:48-05:00http://www.cardiobrief.org/2014/11/13/improve-it-trial-paper-wont-be-published-right-away-in-the-new-england-journal-of-medicine/2014-11-13T13:20:25-05:00http://www.cardiobrief.org/2014/11/15/at-the-american-heart-association-you-really-cant-escape-the-new-cholesterol-drugs/2014-11-15T19:29:56-05:00http://www.cardiobrief.org/2014/11/16/big-study-looks-at-length-of-drug-treatment-after-stent-implantation/2014-11-16T16:54:33-05:00http://www.cardiobrief.org/2014/11/17/improve-it-meets-endpoint-and-demonstrates-real-but-modest-clinical-benefit-for-ezetimibe/2014-11-17T15:31:18-05:00http://www.cardiobrief.org/2014/11/17/large-japanese-trial-casts-further-doubt-on-aspirin-to-prevent-a-first-heart-attack/2014-11-17T15:57:04-05:00http://www.cardiobrief.org/2014/11/18/hdl-raising-drugs-probably-wont-work-but-this-might/2014-11-18T15:55:00-05:00http://www.cardiobrief.org/2014/11/19/losartan-no-better-than-atenolol-in-marfans-syndrome/2014-11-19T11:35:27-05:00http://www.cardiobrief.org/2014/11/19/us-proposal-would-greatly-expand-transparency-of-clinical-trials/2014-11-19T12:51:23-05:00http://www.cardiobrief.org/2014/11/24/intent-to-tweet-and-a-failure-of-communication/2014-11-24T09:27:24-05:00http://www.cardiobrief.org/2014/11/24/european-review-confirms-increased-risk-with-ivabradine/2014-11-24T17:12:24-05:00http://www.cardiobrief.org/2014/11/26/fda-approves-new-noninvasive-ffr-technology/2014-11-26T16:39:12-05:00http://www.cardiobrief.org/2014/12/01/study-suggests-epinephrine-for-cardiac-arrest-may-be-harmful/2014-12-01T18:53:28-05:00http://www.cardiobrief.org/2014/12/02/no-the-mediterranean-diet-wont-help-you-live-forever/2014-12-02T18:58:58-05:00http://www.cardiobrief.org/2014/12/05/women-dont-use-aspirin-for-routine-prevention-of-heart-attacks-stroke-and-cancer/2014-12-05T10:06:49-05:00http://www.cardiobrief.org/2014/12/07/new-drug-from-isis-breaks-important-ground-but-unlikely-to-dent-the-market/2014-12-07T14:22:33-05:00http://www.cardiobrief.org/2014/12/10/get-rid-of-sugar-not-salt-say-authors/2014-12-10T20:06:51-05:00http://www.cardiobrief.org/2014/12/18/cardiology-drugs-of-the-year-new-old-and-not-so-funny/2014-12-18T14:30:38-05:00http://www.cardiobrief.org/2014/12/23/2014-dubious-innovations-in-cardiology/2014-12-23T09:17:20-05:00http://www.cardiobrief.org/2014/12/16/no-advantage-for-low-glycemic-index-diet/2014-12-16T16:31:12-05:00http://www.cardiobrief.org/2014/12/16/continuing-medical-education-payments-to-physicians-will-be-exposed-to-sunshine/2014-12-16T20:04:22-05:00http://www.cardiobrief.org/2014/12/17/new-devices-may-bring-improved-treatment-to-stroke-patients/2014-12-17T16:27:35-05:00http://www.cardiobrief.org/2014/12/17/embattled-stem-cell-researchers-sue-harvard-and-brigham-and-womens-hospital/2014-12-17T20:12:18-05:00http://www.cardiobrief.org/2015/01/05/fda-approves-new-medtronic-drug-coated-balloon-to-open-blocked-leg-arteries/2015-01-05T12:21:53-05:00http://www.cardiobrief.org/2015/01/05/healthy-habits-of-young-women-lead-to-long-term-health-benefits/2015-01-05T15:46:52-05:00http://www.cardiobrief.org/2015/01/07/an-emerging-consensus-about-novartiss-new-potential-blockbuster/2015-01-07T08:06:30-05:00http://www.cardiobrief.org/2015/01/08/fda-approves-new-oral-anticoagulant-from-daiichi-sankyo/2015-01-08T19:52:38-05:00http://www.cardiobrief.org/2015/01/09/three-reasons-why-you-dont-need-to-feel-sorry-for-doctors/2015-09-15T20:00:21-04:00http://www.cardiobrief.org/2015/01/12/more-turmoil-for-troubled-medical-laboratory-company/2015-01-12T13:44:53-05:00http://www.cardiobrief.org/2015/01/12/millions-of-americans-taking-aspirin-when-they-shouldnt/2015-01-12T16:18:12-05:00http://www.cardiobrief.org/2015/01/13/success-for-40-year-effort-in-one-rural-county-to-curb-cardiovascular-disease/2015-01-13T11:07:07-05:00http://www.cardiobrief.org/2015/01/14/astrazeneca-drug-improves-outcomes-after-heart-attacks/2015-01-14T14:33:24-05:00http://www.cardiobrief.org/2015/01/14/buried-clinical-trial-data-the-dam-is-about-to-burst/2015-01-14T17:05:53-05:00http://www.cardiobrief.org/2015/01/19/how-much-salt-should-old-people-consume/2015-01-19T11:28:25-05:00http://www.cardiobrief.org/2015/01/20/intense-exercise-doesnt-eliminate-the-hazard-of-intense-sitting/2015-01-20T09:25:41-05:00http://www.cardiobrief.org/2015/01/22/why-doctors-like-airline-pilots-should-not-be-completely-trusted/2015-09-15T20:00:38-04:00http://www.cardiobrief.org/2015/01/22/new-device-to-lower-resistant-high-blood-pressure-shows-early-promise/2015-01-22T19:49:43-05:00http://www.cardiobrief.org/2015/01/23/salt-science-and-the-american-heart-associations-double-standard/2015-09-15T20:00:54-04:00http://www.cardiobrief.org/2015/01/26/sanofi-and-regeneron-leapfrog-amgen-in-new-cholesterol-drug-race/2015-01-26T08:48:33-05:00http://www.cardiobrief.org/2015/01/26/califf-to-leave-duke-to-become-fda-deputy-commissioner/2015-01-26T14:15:46-05:00http://www.cardiobrief.org/2015/01/27/can-precision-medicine-do-better-than-precision-weather/2015-01-27T10:24:15-05:00http://www.cardiobrief.org/2015/01/28/fda-approves-new-heart-pump-from-abiomed/2015-01-28T16:51:19-05:00http://www.cardiobrief.org/2015/01/29/study-tests-high-blood-pressure-control-during-pregnancy/2015-01-29T13:54:04-05:00http://www.cardiobrief.org/2015/02/03/no-too-much-jogging-probably-wont-kill-you/2015-09-15T20:02:42-04:00http://www.cardiobrief.org/2015/02/05/novel-device-offers-hope-for-heart-patients-with-no-alternatives/2015-02-05T11:16:35-05:00http://www.cardiobrief.org/2015/02/09/new-heart-drug-from-novartis-will-it-raise-the-risk-of-alzheimers-disease/2015-02-09T09:03:12-05:00http://www.cardiobrief.org/2015/02/10/another-study-raises-questions-about-blood-pressure-guidelines/2015-02-10T11:10:26-05:00http://www.cardiobrief.org/2015/02/10/new-us-guidelines-will-lift-limits-on-dietary-cholesterol/2015-02-10T19:38:52-05:00http://www.cardiobrief.org/2015/02/11/three-trials-show-benefits-of-thrombectomy-in-stroke-patients/2015-02-11T16:13:06-05:00http://www.cardiobrief.org/2015/02/16/very-simple-high-fiber-diet-stands-up-to-american-heart-association-diet/2015-02-16T17:07:23-05:00http://www.cardiobrief.org/2015/02/17/more-guideline-controversy-the-tricky-business-of-calculating-cardiovascular-risk/2015-02-17T09:49:26-05:00http://www.cardiobrief.org/2015/02/18/no-the-new-cholesterol-drugs-from-sanofi-and-amgen-arent-going-to-cost-150-billion-a-year/2015-02-18T16:10:00-05:00http://www.cardiobrief.org/2015/02/19/medtronic-and-boston-scientific-plan-to-resume-blood-pressure-trials-this-year/2015-02-19T15:58:32-05:00http://www.cardiobrief.org/2015/02/23/everybody-into-the-sauna/2015-02-23T11:17:17-05:00http://www.cardiobrief.org/2015/02/24/common-pain-drugs-linked-to-more-problems-after-a-heart-attack/2015-02-24T13:20:35-05:00http://www.cardiobrief.org/2015/02/25/new-york-city-ebola-doctor-slams-media-and-governors-christie-and-cuomo/2015-02-25T17:07:33-05:00http://www.cardiobrief.org/2015/03/02/hospitals-like-vampires-want-your-blood/2015-03-02T08:51:06-05:00http://www.cardiobrief.org/2015/03/03/no-drinking-coffee-wont-save-your-life-or-prevent-heart-attacks/2015-09-20T18:03:06-04:00http://www.cardiobrief.org/2015/03/03/orexigen-released-interim-data-without-approval-of-trial-leaders/2015-09-15T20:02:11-04:00http://www.cardiobrief.org/2015/03/05/takeda-disagrees-with-orexigen-over-data-disclosure/2015-03-05T12:33:29-05:00http://www.cardiobrief.org/2015/03/05/orexigen-crying-all-the-way-to-the-bank-after-egregiously-unethical-actions/2015-03-05T14:04:32-05:00http://www.cardiobrief.org/2015/03/09/study-uncovers-confusion-about-when-to-use-an-important-heart-test/2015-03-09T17:27:59-04:00http://www.cardiobrief.org/2015/03/10/high-risks-and-rewards-found-with-heart-valve-device-from-edwards-and-medtronic/2015-03-10T12:29:10-04:00http://www.cardiobrief.org/2015/03/13/what-a-long-strange-trip-its-been-fda-approves-watchman-device-from-boston-scientific/2015-03-13T21:12:38-04:00http://www.cardiobrief.org/2015/03/14/astrazeneca-drug-approaching-the-point-of-diminishing-returns/2015-03-14T11:13:04-04:00http://www.cardiobrief.org/2015/03/14/has-ct-angiography-lived-up-to-its-early-promise/2015-03-14T13:20:01-04:00http://www.cardiobrief.org/2015/03/15/new-cholesterol-drugs-highly-effective-but-important-questions-remain/2015-03-15T12:01:33-04:00http://www.cardiobrief.org/2015/03/15/encouraging-long-term-results-for-less-invasive-heart-valves/2015-03-15T16:51:39-04:00http://www.cardiobrief.org/2015/03/16/should-you-be-worried-about-the-neurocognitive-side-effects-of-the-new-cholesterol-drugs/2015-03-16T08:36:18-04:00http://www.cardiobrief.org/2015/03/16/a-requiem-for-routine-clot-removal-during-heart-attacks/2015-03-16T14:25:55-04:00http://www.cardiobrief.org/2015/03/23/gileads-hepatitis-drugs-tripped-by-old-heart-drug/2015-03-23T12:22:36-04:00http://www.cardiobrief.org/2015/03/24/fda-grants-premarket-approval-to-abiomed-heart-pump/2015-03-24T09:21:53-04:00http://www.cardiobrief.org/2015/03/24/embattled-lab-nears-settlement-with-government-over-kickbacks/2015-03-24T12:31:13-04:00http://www.cardiobrief.org/2015/03/30/no-an-apple-a-day-wont-keep-the-doctor-away/2015-03-30T11:21:31-04:00http://www.cardiobrief.org/2015/03/31/doctors-halt-squabbling-and-agree-how-to-manage-hypertension-in-people-with-blocked-arteries/2015-03-31T16:44:08-04:00http://www.cardiobrief.org/2015/04/01/global-cardiovascular-deaths-continue-to-rise-despite-gains-in-prevention-and-treatment/2015-04-01T17:08:23-04:00http://www.cardiobrief.org/2015/04/02/mark-cuban-should-take-the-cigar-out-of-his-mouth-and-stop-giving-health-advice/2015-12-26T14:10:37-05:00http://www.cardiobrief.org/2015/04/06/15971/2015-09-15T20:03:58-04:00http://www.cardiobrief.org/2015/04/06/weight-loss-programs-slim-evidence-and-poor-results/2015-04-06T17:09:07-04:00http://www.cardiobrief.org/2015/04/10/doj-settles-with-embattled-lab-criminal-charges-for-executives-still-possible/2015-04-10T13:27:58-04:00http://www.cardiobrief.org/2015/04/12/two-dirty-little-secrets-about-electronic-health-records/2015-09-15T20:03:43-04:00http://www.cardiobrief.org/2015/04/14/heart-attack-risk-jumps-after-divorce/2015-04-14T17:40:47-04:00http://www.cardiobrief.org/2015/04/14/diabetes-drugs-get-neither-restrictions-nor-endorsements-from-fda-committee/2015-04-14T20:09:57-04:00http://www.cardiobrief.org/2015/04/15/fda-approves-amgen-heart-failure-drug/2015-04-15T18:09:08-04:00http://www.cardiobrief.org/2015/04/16/medicines-company-drug-finally-gets-nod-from-fda-advisory-panel/2015-04-16T11:31:26-04:00http://www.cardiobrief.org/2015/04/21/inside-the-scandal-profit-and-greed-at-an-embattled-laboratory-company/2015-09-15T20:06:01-04:00http://www.cardiobrief.org/2015/04/27/more-preliminary-signs-that-pcsk9-inhibitors-may-improve-outcomes/2015-04-27T17:16:01-04:00http://www.cardiobrief.org/2015/04/27/cardiovascular-outcomes-with-mercks-januvia-no-better-or-worse-than-conventional-care/2015-04-27T19:02:34-04:00http://www.cardiobrief.org/2015/04/28/american-heart-association-cancels-baltimore-conference/2015-04-28T11:12:11-04:00http://www.cardiobrief.org/2015/04/29/no-benefit-for-a-commonly-used-cardiac-device/2015-04-29T16:50:30-04:00http://www.cardiobrief.org/2015/04/30/more-evidence-linking-sugared-drinks-to-diabetes/2015-04-30T18:19:46-04:00http://www.cardiobrief.org/2015/06/04/another-one-bites-the-dust-on-the-death-of-a-social-media-site-for-doctors/2015-06-04T10:36:07-04:00http://www.cardiobrief.org/2015/05/05/200-year-old-heart-drug-linked-to-increased-risk-of-death/2015-05-05T10:17:36-04:00http://www.cardiobrief.org/2015/05/06/precision-medicine-approaches-peak-hype/2015-12-26T13:30:40-05:00http://www.cardiobrief.org/2015/05/08/secret-letter-to-doctors-shows-that-the-amarin-lawsuit-is-about-marketing-not-free-speech/2015-05-08T08:19:50-04:00http://www.cardiobrief.org/2015/05/11/prominent-harvard-cardiologist-moves-to-google-x-to-head-large-study/2015-05-11T12:55:53-04:00http://www.cardiobrief.org/2015/05/12/diet-drug-study-crashes-and-burns-in-the-wake-of-leaked-results/2015-05-12T13:23:26-04:00http://www.cardiobrief.org/2015/05/14/get-a-grip-global-study-shows-grip-strength-is-a-simple-and-powerful-predictor-of-death/2015-05-14T10:49:23-04:00http://www.cardiobrief.org/2015/05/21/no-pharmascolds-are-not-worse-than-the-pervasive-conflicts-of-interest-they-criticize/2017-12-17T14:35:47-05:00http://www.cardiobrief.org/2015/05/22/novartis-summer-blockbuster-lcz696-gains-a-name-skips-an-advisory-panel/2015-05-22T09:16:36-04:00http://www.cardiobrief.org/2015/06/08/embattled-laboratory-files-for-bankruptcy/2015-06-08T13:33:16-04:00http://www.cardiobrief.org/2015/06/12/steven-nissen-conflicts-of-interest-and-the-new-cholesterol-drugs/2015-06-16T10:26:25-04:00http://www.cardiobrief.org/2015/06/15/can-you-test-a-drug-and-also-say-negative-things-about-it/2015-06-16T10:29:48-04:00http://www.cardiobrief.org/2015/06/24/fact-check-ny-times-heart-disease-series-gets-it-right-mostly/2015-06-24T14:55:27-04:00http://www.cardiobrief.org/2015/07/06/why-the-internet-stinks-part-1/2015-07-06T15:02:56-04:00http://www.cardiobrief.org/2015/07/07/novartis-heart-failure-drug-gains-speedy-fda-approval/2015-07-07T17:48:43-04:00http://www.cardiobrief.org/2015/07/24/doctor-scorecards-the-wrong-answer-to-the-right-question/2015-07-24T11:22:41-04:00http://www.cardiobrief.org/2015/07/23/300-millions-dollars-of-cardiology-sunshine/2016-06-18T19:44:24-04:00http://www.cardiobrief.org/2015/08/09/what-role-should-coca-cola-play-in-obesity-research-2/2015-08-09T19:28:05-04:00http://www.cardiobrief.org/2015/08/11/the-amarin-decision-free-speech-or-truthiness/2015-09-15T20:07:38-04:00http://www.cardiobrief.org/2015/08/19/farewell-to-forbes-no-i-am-not-dr-oz-nor-was-meant-to-be/2015-08-19T16:46:12-04:00http://www.cardiobrief.org/2015/08/20/wow-maybe-finally-a-positive-diabetes-drug-outcomes-trial/2015-08-21T22:53:45-04:00http://www.cardiobrief.org/2015/08/20/cookie-monster-free-lunch-and-the-new-england-journal-of-medicine/2015-08-20T14:28:00-04:00http://www.cardiobrief.org/2015/08/21/all-the-woo-thats-fit-to-print-an-open-letter-to-the-new-york-times-public-editor/2015-09-15T20:07:09-04:00http://www.cardiobrief.org/2015/08/24/fda-approval-of-second-pcsk9-inhibitor-expected-soon/2015-08-24T13:15:09-04:00http://www.cardiobrief.org/2015/08/26/labor-union-targets-american-heart-association-for-financial-conflicts/2015-08-26T10:26:09-04:00http://www.cardiobrief.org/2015/08/25/ignorance-cardiology-and-the-milky-way-galaxy/2015-08-25T14:18:14-04:00http://www.cardiobrief.org/2015/08/27/fda-approves-repatha-amgens-pcsk9-inhibitor/2015-08-27T18:14:39-04:00http://www.cardiobrief.org/2015/08/28/esc-2015-set-to-start-in-london/2015-08-28T10:15:26-04:00http://www.cardiobrief.org/2015/08/29/hot-lines-simultaneous-publications-and-the-decline-of-medical-meetings/2015-08-29T11:14:45-04:00http://www.cardiobrief.org/2015/08/28/cholesterol-wars-the-reimbursement-battle-begins/2015-08-29T12:06:18-04:00http://www.cardiobrief.org/2015/08/30/novel-drug-could-cut-ldl-with-just-2-or-4-shots-a-year/2015-08-30T10:07:10-04:00http://www.cardiobrief.org/2015/08/31/improve-it-substudy-ezetimibe-benefit-restricted-to-diabetics/2015-09-01T10:57:43-04:00http://www.cardiobrief.org/2015/09/01/califf-nissen-and-others-agree-and-disagree-about-regulatory-standardskerckhoff-heart-and-thorax-centre-bad-nauheim-germany/2015-09-01T08:07:32-04:00http://www.cardiobrief.org/2015/09/01/no-increase-in-diabetes-found-with-ezetimibe-in-improve-it/2015-09-01T10:55:59-04:00http://www.cardiobrief.org/2015/09/08/its-complicated-large-genetic-study-of-coronary-disease-shows-how-much-we-dont-know/2015-09-08T09:22:30-04:00http://www.cardiobrief.org/2015/09/08/crystals-spiritual-speed-dating-and-the-new-york-times/2015-09-08T12:51:01-04:00http://www.cardiobrief.org/2015/09/08/growing-problem-when-should-drugs-be-discontinued/2015-09-08T16:10:21-04:00http://www.cardiobrief.org/2015/09/08/report-concludes-that-pcsk9-inhibitors-are-effective-but-very-expensive/2015-09-08T19:13:25-04:00http://www.cardiobrief.org/2015/09/09/dont-believe-the-hype/2015-09-09T17:06:42-04:00http://www.cardiobrief.org/2015/09/10/amarin-begins-legal-off-label-promotion-of-vascepa/2015-09-10T11:33:17-04:00http://www.cardiobrief.org/2015/09/11/nih-trial-supports-more-intensive-blood-pressure-targets/2015-09-11T11:29:09-04:00http://www.cardiobrief.org/2015/09/14/a-premature-sprint-to-the-finish-line/2015-09-15T20:08:37-04:00http://www.cardiobrief.org/2015/09/14/cost-effectiveness-of-entresto-and-cardiomems-evaluated/2015-09-14T10:52:27-04:00http://www.cardiobrief.org/2015/09/14/john-markoff-on-the-end-of-moores-law-and-closing-the-door-on-the-terminator/2015-09-14T11:50:13-04:00http://www.cardiobrief.org/2015/09/15/the-dirty-little-secret-about-electronic-health-records/2015-09-15T10:02:23-04:00http://www.cardiobrief.org/2015/09/15/survey-yearly-pay-for-cardiologists-hits-542000/2015-09-23T13:13:21-04:00http://www.cardiobrief.org/2015/09/15/on-empathy-the-only-time-i-remember-seeing-a-physician-touch-my-father/2015-09-15T12:00:18-04:00http://www.cardiobrief.org/2016/02/24/vulnerable-plaque-the-paradigm-that-failed/2016-02-24T08:42:05-05:00http://www.cardiobrief.org/2015/09/15/president-obama-nominates-cardiologist-rob-califf-to-lead-fda/2015-09-16T08:31:29-04:00http://www.cardiobrief.org/2015/09/17/why-rob-califf-running-the-fda-may-be-like-nixon-in-china/2015-09-17T11:56:44-04:00http://www.cardiobrief.org/2015/09/17/sanjay-kaul-on-the-empa-reg-outcome-study/2015-09-17T13:09:59-04:00http://www.cardiobrief.org/2015/09/18/bankruptcy-judge-approves-sales-of-embattled-diagnostic-lab-company/2015-09-21T09:56:18-04:00http://www.cardiobrief.org/2015/09/21/required-reading-cardiologists-gone-wild/2015-09-21T12:16:47-04:00http://www.cardiobrief.org/2015/09/24/bmj-paper-criticizes-proposed-us-dietary-guidelines/2015-09-24T15:14:10-04:00http://www.cardiobrief.org/2015/09/22/study-questions-conventional-wisdom-about-trans-fats/2015-09-22T16:12:09-04:00http://www.cardiobrief.org/2015/09/22/the-shaky-scientific-edifice-watching-retracted-and-unretracted-papers/2015-09-23T02:34:24-04:00http://www.cardiobrief.org/2015/09/24/a-coke-a-smile-and-120-million-dollars/2015-09-24T12:56:45-04:00http://www.cardiobrief.org/2015/09/28/second-trial-of-controversial-chelation-therapy-gains-crucial-early-support/2015-09-27T15:32:38-04:00http://www.cardiobrief.org/2015/09/29/double-duty-academic-leaders-on-corporate-boards/2015-09-30T13:21:06-04:00http://www.cardiobrief.org/2015/09/29/sprint-trial-to-be-presented-at-american-heart-association-meeting-in-november/2015-09-29T17:41:32-04:00http://www.cardiobrief.org/2015/09/29/doj-may-soon-announce-settlements-with-hundreds-of-hospitals-over-icd-overuse/2015-09-29T16:33:39-04:00http://www.cardiobrief.org/2015/10/01/new-cholesterol-drugs-not-breaking-the-bank-yet/2015-10-01T10:40:23-04:00http://www.cardiobrief.org/2015/10/05/zero-calcium-score-may-help-many-patients-skip-unwanted-treatment/2015-10-05T14:14:04-04:00http://www.cardiobrief.org/2015/10/05/study-raises-new-questions-about-perioperative-beta-blockers/2015-10-05T12:05:09-04:00http://www.cardiobrief.org/2015/10/05/new-concerns-raised-about-bioprosthetic-aortic-valves/2015-10-05T14:09:31-04:00http://www.cardiobrief.org/2015/10/15/desperately-seeking-patients-new-cholesterol-drug-makers-fuel-research-to-find-customers/2015-10-23T08:56:17-04:00http://www.cardiobrief.org/2015/10/08/new-test-may-allow-early-discharge-of-chest-pain-patients/2015-10-08T13:21:24-04:00http://www.cardiobrief.org/2015/10/06/new-cholesterol-drugs-gain-entry-to-large-formulary/2015-10-06T18:38:36-04:00http://www.cardiobrief.org/2015/10/07/heart-failure-experts-sprint-to-an-early-finish/2015-10-07T09:04:40-04:00http://www.cardiobrief.org/2015/10/07/cardiology-on-a-collision-course-with-specialty-pharmaceutical-pricing-models/2015-10-07T17:07:03-04:00http://www.cardiobrief.org/2015/10/07/possible-setback-for-califf-on-road-to-fda/2015-10-07T15:10:33-04:00http://www.cardiobrief.org/2015/10/12/third-strike-for-cetp-inhibitors-lilly-halts-big-evacetrapib-trial/2015-10-12T12:02:45-04:00http://www.cardiobrief.org/2015/10/12/the-expanding-universe-jama-announces-new-cardiology-journal/2015-10-12T13:07:16-04:00http://www.cardiobrief.org/2015/10/14/but-cardiomyopathy-isnt-supposed-to-be-funny/2015-10-14T19:18:58-04:00http://www.cardiobrief.org/2015/10/16/what-if-the-media-covered-the-world-series-the-same-way-it-covers-science/2015-10-16T09:59:08-04:00http://www.cardiobrief.org/2015/10/16/praising-the-virtues-of-the-familial-hypercholesterolemia-foundation/2015-10-19T14:29:39-04:00http://www.cardiobrief.org/2015/10/18/low-t-and-high-bs-the-role-of-cme/2015-10-18T12:31:11-04:00http://www.cardiobrief.org/2015/10/18/new-york-times-indiana-cardiologist-accused-of-performing-unnecessary-procedures/2015-10-18T13:19:41-04:00http://www.cardiobrief.org/2015/10/19/more-questions-about-nonprofit-groups-and-industry-support/2015-10-23T08:56:04-04:00http://www.cardiobrief.org/2015/10/21/primary-pci-guideline-update-multivessel-interventions-in-thrombectomy-out/2015-10-21T15:07:22-04:00http://www.cardiobrief.org/2015/10/22/new-analysis-finds-small-but-significant-advantage-for-low-carb-diets/2015-10-22T09:52:36-04:00http://www.cardiobrief.org/2015/10/22/amgen-requires-patients-in-repatha-copay-program-to-surrender-their-privacy/2015-11-19T14:25:32-05:00http://www.cardiobrief.org/2015/10/27/coming-attraction-looking-forward-to-sprint-at-the-aha-next-month/2015-10-27T10:03:41-04:00http://www.cardiobrief.org/2015/10/28/does-anyone-really-think-industry-funded-cme-is-independent/2015-12-28T15:35:47-05:00http://www.cardiobrief.org/2015/10/30/studies-suggest-flu-vaccines-may-be-less-effective-in-people-taking-statins/2015-10-30T08:50:44-04:00http://www.cardiobrief.org/2015/10/30/trick-or-treat-hospitals-haunted-by-doj-icd-investigation-settle-for-250-million/2015-11-02T09:09:34-05:00http://www.cardiobrief.org/2015/11/05/new-definition-of-familial-hypercholesterolemia-could-expand-patient-population-for-expensive-cholesterol-drugs/2015-11-05T12:09:50-05:00http://www.cardiobrief.org/2015/11/02/slow-start-for-new-novartis-heart-failure-drug-entresto/2015-11-02T12:28:32-05:00http://www.cardiobrief.org/2015/11/03/clot-extraction-for-stroke-beware-the-hype/2015-11-03T11:01:17-05:00http://www.cardiobrief.org/2015/11/04/should-doctors-tell-patients-they-are-walking-time-bombs/2015-11-04T21:48:26-05:00http://www.cardiobrief.org/2015/11/05/you-dont-know-it-but-the-debate-about-sprint-is-already-over/2015-11-05T14:32:10-05:00http://www.cardiobrief.org/2015/11/09/sprint-will-change-but-not-revolutionize-blood-pressure-treatment/2015-11-09T13:19:31-05:00http://www.cardiobrief.org/2015/11/06/lancet-sprints-to-the-front-with-a-blood-pressure-meta-analysis/2015-11-07T10:53:24-05:00http://www.cardiobrief.org/2015/11/08/waiting-for-ischemia-why-wont-cardiologists-enroll-patients/2015-11-08T20:22:21-05:00http://www.cardiobrief.org/2015/11/10/reality-check-after-starting-warfarin-one-in-five-older-vets-hospitalized-for-bleeding/2015-11-09T23:05:17-05:00http://www.cardiobrief.org/2015/11/11/cms-proposal-would-plug-up-watchman-reimbursement/2015-11-11T14:17:32-05:00http://www.cardiobrief.org/2015/11/16/report-finds-problems-with-fda-mandated-postapproval-device-studies/2015-11-16T11:35:14-05:00http://www.cardiobrief.org/2015/11/13/retiring-editor-says-its-times-for-journals-to-be-retired/2016-08-30T21:26:29-04:00http://www.cardiobrief.org/2015/11/13/merck-reveals-that-its-30000-patient-cetp-trial-will-continue/2015-11-13T10:17:53-05:00http://www.cardiobrief.org/2015/11/19/amgen-takes-the-pledge-to-respect-patient-privacy/2015-11-19T15:09:23-05:00http://www.cardiobrief.org/2015/11/17/live-blog-senate-hearing-on-rob-califfs-nomination-for-fda-commissioner/2015-11-17T12:02:25-05:00http://www.cardiobrief.org/2015/11/17/a-few-observations-about-rob-califfs-picnic-with-the-us-senate/2015-11-17T16:29:17-05:00http://www.cardiobrief.org/2015/11/22/experts-question-role-for-at-home-statin-intolerance-test/2015-11-23T13:47:42-05:00http://www.cardiobrief.org/2015/11/23/amgens-repatha-beats-out-competitor-for-spot-on-cvscaremark-formulary/2015-11-23T13:45:48-05:00http://www.cardiobrief.org/2015/11/24/novel-heart-failure-drug-entresto-gains-approval-in-europe/2015-11-24T14:10:22-05:00http://www.cardiobrief.org/2015/11/30/encouraging-results-found-in-long-term-tavr-registry/2015-11-30T12:39:51-05:00http://www.cardiobrief.org/2015/12/02/paradigm-investigators-estimate-entresto-prolongs-life-by-1-2-years/2015-12-02T20:11:27-05:00http://www.cardiobrief.org/2015/12/03/prominent-european-cardiologists-decry-curbs-on-industry-support-for-docs-attending-medical-meetings/2015-12-05T11:38:13-05:00http://www.cardiobrief.org/2015/11/30/new-questions-raised-about-rocket-af-pivotal-xarelto-trial-chaired-by-califf/2015-12-01T14:48:43-05:00http://www.cardiobrief.org/2015/12/07/survey-docs-think-cardiologists-are-rude-dismissive-and-aggressive/2015-12-07T09:17:43-05:00http://www.cardiobrief.org/2015/12/08/more-concerns-raised-about-possible-risks-of-new-heart-failure-drug/2015-12-08T18:15:30-05:00http://www.cardiobrief.org/2015/12/10/expect-intellectual-fireworks-at-fda-advisory-panel-on-ezetimibe/2015-12-10T14:45:08-05:00http://www.cardiobrief.org/2015/12/13/rocket-af-investigators-seek-to-calm-concerns-about-trial-reliability/2015-12-15T14:07:31-05:00http://www.cardiobrief.org/2015/12/13/pioneering-cardiologist-george-diamond-dead-at-74/2015-12-13T13:29:25-05:00http://www.cardiobrief.org/2015/12/14/live-blog-the-fda-advisory-panel-on-improve-it/2015-12-14T07:52:47-05:00http://www.cardiobrief.org/2015/12/15/fda-panel-turns-down-expanded-indication-for-ezetimibe/2015-12-15T14:00:31-05:00http://www.cardiobrief.org/2015/12/17/prepublish-or-perish-making-a-case-for-medicine-to-take-a-cue-from-basic-science/2015-12-17T17:31:14-05:00http://www.cardiobrief.org/2015/12/19/amgen-denies-rumors-about-pcsk9-inhibitors/2015-12-21T15:14:53-05:00http://www.cardiobrief.org/2015/12/27/2015-the-year-we-finally-cured-heart-disease/2016-08-30T21:25:16-04:00http://www.cardiobrief.org/2015/12/21/first-outcomes-trial-results-for-pcsk9-drugs-will-come-in-2016/2016-06-08T12:14:43-04:00http://www.cardiobrief.org/2015/12/28/paper-raises-more-questions-about-salt-restriction-in-heart-failure/2015-12-28T13:38:20-05:00http://www.cardiobrief.org/2015/12/23/meta-analysis-gives-more-support-to-aggressive-blood-pressure-treatment/2015-12-23T21:30:33-05:00http://www.cardiobrief.org/2016/01/03/rat-study-links-neural-tube-defects-to-lower-pcsk9-levels/2016-01-03T19:42:22-05:00http://www.cardiobrief.org/2016/01/05/jama-study-precision-medicine-flunks-test-gets-left-back-in-second-grade/2016-01-05T11:35:46-05:00http://www.cardiobrief.org/2016/01/07/zombie-laboratory-company-sics-bill-collectors-on-patients-promised-free-tests/2016-05-17T14:19:15-04:00http://www.cardiobrief.org/2016/01/24/new-lab-company-seeks-to-bury-links-to-zombie-lab-and-rogue-sales-team/2016-02-18T19:02:26-05:00http://www.cardiobrief.org/2016/01/12/study-shows-why-sham-controls-are-necessary-for-device-trials/2016-01-12T11:35:07-05:00http://www.cardiobrief.org/2016/01/15/some-come-to-bury-the-stethoscope-some-to-praise-it/2016-01-15T09:47:04-05:00http://www.cardiobrief.org/2016/01/18/recipe-for-disaster-the-new-us-dietary-guidelines/2016-01-22T10:30:30-05:00http://www.cardiobrief.org/2016/01/21/why-guidelines-are-bad-for-science/2016-01-21T12:27:26-05:00http://www.cardiobrief.org/2016/01/20/editors-deliver-major-victory-to-open-data-movement/2016-01-20T14:05:09-05:00http://www.cardiobrief.org/2016/01/25/nejm-editor-flip-flops-on-data-sharing-after-social-media-firestorm/2016-01-25T15:30:20-05:00http://www.cardiobrief.org/2016/01/25/massachusetts-senator-places-hold-on-califfs-fda-nomination/2016-01-28T12:04:25-05:00http://www.cardiobrief.org/2016/01/27/a-lab-industry-veteran-deciphers-the-zombie-lab-enigma/2016-02-18T19:02:35-05:00http://www.cardiobrief.org/2016/01/28/slow-start-for-blockbuster-heart-failure-drug-entresto/2016-01-28T13:34:36-05:00http://www.cardiobrief.org/2016/02/03/new-studies-seek-to-allay-concerns-over-the-rocket-af-trial/2016-02-03T18:31:47-05:00http://www.cardiobrief.org/2016/02/02/entresto-maker-in-deep-water-over-terrifying-tv-advertisement/2016-02-02T16:54:11-05:00http://www.cardiobrief.org/2016/02/11/vampire-lab-turns-to-old-trick-to-grow-business-physician-owned-labs/2016-08-30T21:24:21-04:00http://www.cardiobrief.org/2016/02/04/fda-announces-sweeping-changes-in-approach-to-opioid-drugs/2016-02-04T17:41:44-05:00http://www.cardiobrief.org/2016/02/08/the-real-losers-in-the-zombie-versus-vampire-lab-company-court-battle/2016-02-18T18:57:54-05:00http://www.cardiobrief.org/2016/02/09/deals-seek-to-link-entresto-cost-to-effectiveness/2016-02-09T13:11:20-05:00http://www.cardiobrief.org/2016/02/14/us-freezes-millions-of-dollars-in-assets-of-rogue-lab-sales-force/2016-05-17T14:19:36-04:00http://www.cardiobrief.org/2016/02/15/study-finds-no-improvement-in-quality-of-life-with-esas/2016-02-15T14:35:18-05:00http://www.cardiobrief.org/2016/02/16/fda-turns-down-expanded-indication-for-zetia-and-vytorin/2016-02-16T11:32:47-05:00http://www.cardiobrief.org/2016/02/22/slow-down-dont-sprint-to-more-aggressive-bp-treatment/2016-02-22T11:29:18-05:00http://www.cardiobrief.org/2016/02/25/at-the-fda-rob-califf-will-champion-clinical-trials/2016-02-25T10:48:05-05:00http://www.cardiobrief.org/2016/02/29/shedding-light-on-the-hearts-of-pro-basketball-players/2016-02-29T12:55:51-05:00http://www.cardiobrief.org/2016/03/02/best-selling-smartphone-blood-pressure-app-gave-wrong-results/2016-03-03T11:36:34-05:00http://www.cardiobrief.org/2016/03/03/large-genetic-studies-support-role-for-triglycerides-in-cardiovascular-disease/2016-03-07T14:20:56-05:00http://www.cardiobrief.org/2016/03/08/controversial-ill-fated-obesity-drug-trial-published-in-jama/2016-03-08T10:01:40-05:00http://www.cardiobrief.org/2016/03/04/top-line-results-favor-victoza-in-large-cardiovascular-outcomes-trial/2016-03-04T10:45:07-05:00http://www.cardiobrief.org/2016/03/08/theranos-ignored-red-flags-on-its-blood-clot-tests/2016-03-08T19:32:58-05:00http://www.cardiobrief.org/2016/03/09/the-door-opens-wider-for-drug-companies-to-make-off-label-claims/2016-03-09T10:17:17-05:00http://www.cardiobrief.org/2016/03/11/studies-spotlight-role-of-triglycerides-put-hdl-in-the-background/2016-03-10T19:47:54-05:00http://www.cardiobrief.org/2016/03/14/how-many-people-really-have-familial-hypercholesterolemia-and-does-it-matter/2016-03-14T12:48:44-04:00http://www.cardiobrief.org/2016/03/15/confusion-in-the-age-of-genetic-information/2016-03-21T13:18:47-04:00http://www.cardiobrief.org/2016/03/17/a-novel-way-to-think-about-primary-prevention-death-and-statins/2016-03-17T12:24:24-04:00http://www.cardiobrief.org/2016/03/21/new-evidence-fitness-trackers-dont-actually-track-fitness/2016-03-21T11:07:55-04:00http://www.cardiobrief.org/2016/03/22/lvads-prolong-life-but-sow-confusion/2016-03-22T12:53:59-04:00http://www.cardiobrief.org/2016/03/23/court-decision-in-patent-battle-threatens-pcsk9-drug/2016-03-23T12:45:18-04:00http://www.cardiobrief.org/2016/03/23/top-hf-expert-decries-unbelievable-folly-of-clinical-trials-and-guidelines/2016-03-23T16:50:38-04:00http://www.cardiobrief.org/2016/03/28/how-should-sprint-influence-high-blood-pressure-in-children-and-adolescents/2016-03-28T15:05:52-04:00http://www.cardiobrief.org/2016/03/29/us-doj-expands-investigation-into-phony-novartis-speaking-events/2016-03-29T14:46:32-04:00http://www.cardiobrief.org/2016/04/02/how-does-hope-3-change-thinking-about-primary-prevention/2016-04-02T14:06:49-04:00http://www.cardiobrief.org/2016/04/03/accelerate-puts-the-brake-on-cetp-inhibition/2016-04-02T23:29:40-04:00http://www.cardiobrief.org/2016/04/03/not-so-rare-fh-is-truly-risky-lipid-disorder/2016-04-03T18:57:21-04:00http://www.cardiobrief.org/2016/04/04/after-a-decade-cabg-pulls-ahead-of-meds-for-hf/2016-04-04T08:38:00-04:00http://www.cardiobrief.org/2016/04/04/atmosphere-heart-failure-trial-poisoned-by-controversy/2016-04-04T13:20:06-04:00http://www.cardiobrief.org/2016/04/06/fda-adds-heart-failure-warning-to-saxagliptin-and-alogliptin-labels/2016-04-06T12:59:54-04:00http://www.cardiobrief.org/2016/04/06/pnas-paper-by-prominent-cardiologist-and-dean-retracted/2016-04-06T14:04:08-04:00http://www.cardiobrief.org/2016/04/10/fda-expands-metformin-label/2016-04-11T12:04:55-04:00http://www.cardiobrief.org/2016/04/11/uspstf-updates-aspirin-for-primary-prevention-recommendation/2016-04-11T13:54:41-04:00http://www.cardiobrief.org/2016/04/13/new-analysis-of-old-study-delivers-another-blow-to-traditional-diet-advice/2016-04-13T11:39:33-04:00http://www.cardiobrief.org/2016/04/13/orexigen-terminates-another-cardiovascular-outcomes-trial/2016-04-15T10:17:39-04:00http://www.cardiobrief.org/2016/04/17/fda-ends-niacin-and-fenofibric-acid-combinations-with-statins/2016-04-17T20:00:09-04:00http://www.cardiobrief.org/2016/04/20/new-company-bets-hundreds-of-millions-of-dollars-on-a-genetic-strategy-to-resurrect-a-cetp-inhibitor/2016-04-20T09:40:30-04:00http://www.cardiobrief.org/2016/04/20/no-evidence-to-support-screening-young-athletes/2016-04-20T16:51:43-04:00http://www.cardiobrief.org/2016/04/21/companies-plan-to-study-diabetes-drug-in-heart-failure-population/2016-04-25T10:18:27-04:00http://www.cardiobrief.org/2016/04/25/stent-pioneers-company-in-bankruptcy-and-under-investigation/2016-04-25T14:47:52-04:00http://www.cardiobrief.org/2016/04/27/new-cardio-drugs-off-to-very-slow-start/2016-04-27T09:47:51-04:00http://www.cardiobrief.org/2016/05/02/experts-foresee-major-role-for-generic-crestor/2016-05-02T11:23:00-04:00http://www.cardiobrief.org/2016/05/03/on-road-to-bankruptcy-a-stent-company-invested-in-marty-leons-vc-fund/2016-08-30T21:22:20-04:00http://www.cardiobrief.org/2016/05/05/social-media-and-medical-journals-the-streetlight-effect/2016-05-06T08:51:44-04:00http://www.cardiobrief.org/2016/05/06/pioneering-lipoprotein-researcher-richard-havel-dead/2016-05-06T08:38:19-04:00http://www.cardiobrief.org/2016/05/09/increasing-support-for-generic-drugs-and-therapeutic-substitution/2016-05-10T14:52:42-04:00http://www.cardiobrief.org/2016/05/10/noted-skeptic-calls-for-more-randomized-nutrition-trials/2016-05-10T11:13:06-04:00http://www.cardiobrief.org/2016/05/17/you-say-potato-i-say-worthless-epidemiology/2016-05-18T15:36:12-04:00http://www.cardiobrief.org/2016/05/18/asgr1-gene-tied-to-heart-health/2016-05-19T13:12:33-04:00http://www.cardiobrief.org/2016/05/19/novartis-announces-enormous-clinical-trial-program-for-heart-failure-drug/2016-05-19T13:44:16-04:00http://www.cardiobrief.org/2016/05/20/entresto-gets-boost-in-updated-hf-guidelines/2016-05-23T12:53:24-04:00http://www.cardiobrief.org/2016/05/22/study-suggests-salt-restriction-only-beneficial-in-people-with-hypertension/2016-05-27T09:39:40-04:00http://www.cardiobrief.org/2016/05/24/flu-vaccine-may-benefit-heart-failure-patients/2016-05-24T09:30:28-04:00http://www.cardiobrief.org/2016/05/25/the-american-heart-associations-strong-stance-against-science/2016-08-30T21:21:50-04:00http://www.cardiobrief.org/2016/05/27/new-anticoagulant-may-cut-vte-in-medically-ill/2016-05-27T09:07:30-04:00http://www.cardiobrief.org/2016/05/31/women-with-migraine-face-increased-cv-risk/2016-05-31T14:05:41-04:00http://www.cardiobrief.org/2016/06/01/fda-proposes-voluntary-sodium-cuts-by-food-industry/2016-06-01T16:17:58-04:00http://www.cardiobrief.org/2016/06/08/documents-reveal-rogue-laboratory-companys-unorthodox-billing-practices/2016-08-30T21:21:26-04:00http://www.cardiobrief.org/2016/06/07/prominent-cardiologist-and-esc-presidential-candidate-found-guilty-of-fraud/2016-06-08T09:19:17-04:00http://www.cardiobrief.org/2016/06/08/first-pcsk9-outcome-trial-results-pushed-back-to-2017/2017-02-07T16:33:23-05:00http://www.cardiobrief.org/2016/06/13/clinical-trial-experts-deep-dive-into-the-important-new-liraglutide-trial/2016-06-13T16:34:37-04:00http://www.cardiobrief.org/2016/06/15/cholesterol-skeptics-launch-another-attack/2016-06-14T22:56:18-04:00http://www.cardiobrief.org/2016/06/20/study-questions-lower-is-better-for-cholesterol/2016-06-20T10:31:28-04:00http://www.cardiobrief.org/2016/06/20/the-hidden-cost-of-free-lunch/2016-06-25T20:44:38-04:00http://www.cardiobrief.org/2016/06/22/time-for-cardiologists-to-start-prescribing-diabetes-drugs/2016-06-22T14:06:29-04:00http://www.cardiobrief.org/2016/06/24/unforced-error-pharma-supporter-attacks-the-wrong-paper/2016-06-24T09:52:52-04:00http://www.cardiobrief.org/2016/06/24/empagliflozin-may-be-poised-to-gain-cv-indication/2016-06-24T18:41:02-04:00http://www.cardiobrief.org/2016/06/28/bad-news-bears-after-scary-headlines-some-patients-stopped-taking-statins/2016-06-28T16:18:30-04:00http://www.cardiobrief.org/2016/06/30/fda-places-roadblock-on-approval-path-of-novel-cholesterol-drug/2016-06-30T16:47:22-04:00http://www.cardiobrief.org/2016/07/05/prominent-cardiologists-decry-tepid-support-for-empagliflozin-by-endocrinologists/2016-07-05T09:35:07-04:00http://www.cardiobrief.org/2016/07/11/the-wild-west-of-new-laboratory-scams/2016-08-30T21:20:45-04:00http://www.cardiobrief.org/2016/07/06/rocket-af-investigators-say-new-analysis-supports-original-trial-results/2016-07-07T10:52:41-04:00http://www.cardiobrief.org/2016/07/12/reality-check-on-the-noninferior-abbott-bioresorbable-stent/2016-07-12T09:27:04-04:00http://www.cardiobrief.org/2016/07/11/repatha-approved-for-single-monthly-injection/2016-07-11T22:39:10-04:00http://www.cardiobrief.org/2016/07/13/alere-withdraws-anticoagulation-monitoring-system-at-heart-of-rocket-af-controversy/2016-07-13T09:48:18-04:00http://www.cardiobrief.org/2016/07/18/the-billion-dollar-lab-scandal/2016-08-30T21:20:23-04:00http://www.cardiobrief.org/2016/07/22/interventional-cardiology-and-the-rejection-of-science/2016-08-30T21:20:11-04:00http://www.cardiobrief.org/2016/07/26/cardiac-surgery-and-clinical-trials/2016-07-26T16:05:31-04:00http://www.cardiobrief.org/2016/07/29/changes-in-eskimo-diet-linked-to-increase-in-heart-disease/2016-07-29T11:07:38-04:00http://www.cardiobrief.org/2016/08/01/pioneering-interventional-cardiologist-defends-unorthodox-practices/2016-08-05T11:59:52-04:00http://www.cardiobrief.org/2016/08/02/the-big-dirty-secret-every-doctor-knows/2016-08-30T21:19:54-04:00http://www.cardiobrief.org/2016/08/03/top-clinical-investigators-seek-to-dampen-impact-of-data-sharing/2016-08-30T21:19:45-04:00http://www.cardiobrief.org/2016/08/05/clinical-trialists-dig-in-and-vote-for-status-quo/2016-08-30T21:19:34-04:00http://www.cardiobrief.org/2016/08/10/experts-disagree-about-cholesterol-screening-in-kids/2016-08-11T14:29:31-04:00http://www.cardiobrief.org/2016/08/11/the-twitter-debate-over-cholesterol-screening-in-kids/2016-08-11T14:27:10-04:00http://www.cardiobrief.org/2016/08/15/major-shift-as-deaths-from-cancer-overtake-cv-disease-in-western-europe/2016-08-15T09:56:12-04:00http://www.cardiobrief.org/2016/08/15/can-50-million-blood-pressure-prescriptions-each-year-be-wrong/2016-08-15T12:40:15-04:00http://www.cardiobrief.org/2016/08/17/imprecise-medicine-genetic-tests-lead-to-misdiagnosis/2016-08-17T18:01:35-04:00http://www.cardiobrief.org/2016/08/17/fda-delays-approval-of-first-agent-to-reverse-effect-of-new-anticoagulants/2016-08-17T23:55:29-04:00http://www.cardiobrief.org/2016/08/23/anticipated-heart-failure-trial-delayed-until-november/2016-08-23T16:39:49-04:00http://www.cardiobrief.org/2016/08/24/dollars-for-heart-docs-2015-edition/2016-08-30T21:18:50-04:00http://www.cardiobrief.org/2016/08/28/cardiologists-thumbs-down-to-sprint/2017-02-07T14:36:47-05:00http://www.cardiobrief.org/2016/08/29/new-heart-failure-drug-struggles-to-find-its-footing/2016-08-29T13:44:11-04:00http://www.cardiobrief.org/2016/08/30/experts-weigh-in-on-the-decline-in-cardiovascular-drug-development/2016-08-30T13:38:42-04:00http://www.cardiobrief.org/2016/09/06/sprint-more-controversy-and-confusion-about-landmark-trial/2017-10-05T19:00:57-04:00http://www.cardiobrief.org/2016/09/08/statin-trialists-seek-to-bury-debate-with-evidence/2016-09-08T16:51:04-04:00http://www.cardiobrief.org/2016/09/12/guest-post-jacc-retracts-af-ablation-trial/2016-09-12T11:21:22-04:00http://www.cardiobrief.org/2016/09/13/how-sweet-sugar-industry-made-fat-the-villain/2016-09-13T08:53:30-04:00http://www.cardiobrief.org/2016/09/15/sprinting-to-lower-bp-targets-not-so-fast/2016-09-15T14:27:28-04:00http://www.cardiobrief.org/2016/09/15/the-lancet-versus-bmj-dispatch-from-the-statin-wars/2016-12-15T09:19:45-05:00http://www.cardiobrief.org/2016/09/18/zombie-lab-company-sics-bill-collectors-on-doctors-who-took-kickbacks/2016-09-18T19:45:15-04:00http://www.cardiobrief.org/2016/09/20/american-heart-association-and-american-society-of-hypertension-explore-merger/2016-09-20T13:46:44-04:00http://www.cardiobrief.org/2016/09/21/debate-switching-from-standard-hf-therapy-to-entresto/2016-09-21T20:13:16-04:00http://www.cardiobrief.org/2016/09/21/zombie-lab-sues-former-execs-owners-and-sales-force/2016-09-21T16:20:39-04:00http://www.cardiobrief.org/2016/09/27/nih-funds-second-round-of-controversial-chelation-tria/2016-09-27T09:23:29-04:00http://www.cardiobrief.org/2016/09/28/more-blasts-of-concern-over-rocket-af/2016-09-28T18:15:18-04:00http://www.cardiobrief.org/2016/10/04/ticagrelor-no-better-than-clopidogrel-in-peripheral-artery-disease/2016-10-04T10:59:34-04:00http://www.cardiobrief.org/2016/10/04/more-bleeding-linked-to-rivaroxaban-in-observational-study/2016-10-04T14:54:38-04:00http://www.cardiobrief.org/2016/10/05/trumps-risk-for-a-cardiac-event-is-seven-times-hilary-clintons-risk/2016-10-05T10:20:42-04:00http://www.cardiobrief.org/2016/10/06/ldl-lowering-genetic-variants-linked-to-diabetes-risk/2016-10-06T11:39:42-04:00http://www.cardiobrief.org/2016/10/07/no-75-million-wont-cure-heart-disease-or-reinvent-science/2016-10-07T10:01:07-04:00http://www.cardiobrief.org/2016/10/11/fda-reaffirms-safety-and-efficacy-of-rivaroxaban/2016-10-11T14:52:04-04:00http://www.cardiobrief.org/2016/10/12/calcium-supplements-linked-to-increased-cardiovascular-risk/2016-10-12T15:30:50-04:00http://www.cardiobrief.org/2016/10/17/caffeine-study-gives-heart-failure-patients-green-light-to-drink-coffee/2016-10-18T10:01:12-04:00http://www.cardiobrief.org/2016/10/18/novel-cholesterol-drugs-move-forward-in-clinical-trials/2016-10-18T13:22:04-04:00http://www.cardiobrief.org/2016/10/20/eliquis-nipping-at-the-heals-of-noac-market-leader-xarelto/2016-10-20T12:13:11-04:00http://www.cardiobrief.org/2016/10/24/calcium-levels-and-cv-risk-new-study-finds-no-link/2016-10-24T13:21:24-04:00http://www.cardiobrief.org/2016/10/26/universal-child-fh-screening-proposed/2016-10-26T16:52:51-04:00http://www.cardiobrief.org/2016/10/30/impella-no-better-than-iabp-in-cardiogenic-shock/2016-10-30T13:49:40-04:00http://www.cardiobrief.org/2016/10/30/debaters-at-interventional-cardiology-meeting-literally-put-the-gloves-on/2016-12-12T17:28:36-05:00http://www.cardiobrief.org/2016/11/01/pfizers-ends-development-of-its-pcsk9-inhibitor/2016-11-01T13:21:24-04:00http://www.cardiobrief.org/2016/11/02/the-impact-of-absorb-ii-down-the-slippery-slope/2016-11-02T16:49:50-04:00http://www.cardiobrief.org/2016/11/04/early-watchman-experience-reassuring-but-many-questions-remain/2016-11-04T09:50:07-04:00http://www.cardiobrief.org/2016/11/07/cardiac-devices-could-become-a-big-problem-for-califf-and-the-fda/2016-11-07T18:16:06-05:00http://www.cardiobrief.org/2016/11/08/novel-cholesterol-therapy-flops-and-company-ends-development/2016-11-08T10:19:42-05:00http://www.cardiobrief.org/2016/11/13/debate-ensures-as-uspstf-finalizes-statin-primary-prevention-guideline/2016-11-13T11:02:51-05:00http://www.cardiobrief.org/2016/11/13/no-cognitive-benefit-from-heart-drugs-in-hope-3/2016-11-13T16:15:30-05:00http://www.cardiobrief.org/2016/11/13/long-term-benefit-in-hf-patients-elusive-for-novel-vasodilator/2016-11-13T16:10:58-05:00http://www.cardiobrief.org/2016/11/14/is-the-american-heart-association-trying-to-kill-health-reporters/2016-12-12T17:27:54-05:00http://www.cardiobrief.org/2016/11/14/statin-nation-census-highlights-major-disparities/2016-11-14T10:44:07-05:00http://www.cardiobrief.org/2016/11/15/more-progress-for-novel-pcsk9-drug/2016-11-15T12:03:17-05:00http://www.cardiobrief.org/2016/11/15/lunchroom-scandal-at-the-aha-day-two-of-buttergate/2016-12-12T17:28:02-05:00http://www.cardiobrief.org/2016/11/16/mixed-results-for-apoa-1-therapies/2016-11-16T11:41:36-05:00http://www.cardiobrief.org/2016/11/20/how-the-internet-brought-us-to-donald-trump/2016-11-21T09:44:11-05:00http://www.cardiobrief.org/2016/11/23/guest-post-two-nations-separated-by-5-3-mm/2016-11-23T17:07:39-05:00http://www.cardiobrief.org/2016/11/27/saturated-fats-linked-to-heart-disease-once-again/2016-11-27T18:24:35-05:00http://www.cardiobrief.org/2016/11/29/prenatal-genetic-test-billing-practices-questioned/2016-11-29T09:30:23-05:00http://www.cardiobrief.org/2016/11/30/genetic-studies-offer-hint-of-clinical-benefits-and-risks-of-pcsk9-inhibitors/2016-11-30T16:45:06-05:00http://www.cardiobrief.org/2016/12/04/telling-people-what-they-want-to-hear-alt-med-and-donald-trump/2016-12-12T17:27:29-05:00http://www.cardiobrief.org/2016/12/09/seeking-profit-and-investors-rogue-lab-moves-into-small-hospitals/2016-12-09T09:05:08-05:00http://www.cardiobrief.org/2016/12/06/the-giveaway-act/2016-12-06T15:05:07-05:00http://www.cardiobrief.org/2016/12/21/2016-great-year-or-greatest-year-ever/2016-12-21T10:03:18-05:00http://www.cardiobrief.org/2016/12/15/novartis-contest-rewards-positive-peer-review-articles-about-entresto/2016-12-20T11:19:06-05:00http://www.cardiobrief.org/2016/12/19/novartis-withdraws-support-for-controversial-entresto-contest/2016-12-19T15:54:33-05:00http://www.cardiobrief.org/2016/12/19/more-shots-fired-in-sugar-war/2016-12-21T18:45:54-05:00http://www.cardiobrief.org/2017/01/04/screen-and-treat-to-prevent-diabetes-doomed-to-fail/2017-01-04T17:22:28-05:00http://www.cardiobrief.org/2017/01/23/long-unsuccessful-heart-failure-drug-once-again-at-center-of-controversy/2017-01-23T17:09:41-05:00http://www.cardiobrief.org/2017/01/27/in-which-i-go-under-the-knife-and-learn-about-medicine-in-the-real-world/2017-02-01T20:02:11-05:00http://www.cardiobrief.org/2017/02/02/27000-patient-pcsk9-inhibitor-trial-meets-main-endpoints/2017-02-02T19:36:28-05:00http://www.cardiobrief.org/2017/02/08/new-questions-raised-about-sprint/2017-02-08T10:56:04-05:00http://www.cardiobrief.org/2017/02/08/enormous-rivaroxaban-study-stopped-early-for-overwhelming-efficacy/2017-02-08T16:34:47-05:00http://www.cardiobrief.org/2017/02/14/international-experts-call-salt-guidelines-far-too-restrictive/2017-02-14T12:42:10-05:00http://www.cardiobrief.org/2017/02/20/after-yet-another-failure-stem-cell-leaders-double-down/2017-02-20T19:18:51-05:00http://www.cardiobrief.org/2017/02/27/top-cardiologist-blasts-nutrition-guidelines/2017-02-27T09:33:54-05:00http://www.cardiobrief.org/2017/03/06/call-for-more-calcium-screening-gets-pushback/2017-03-06T14:24:13-05:00http://www.cardiobrief.org/2017/03/09/has-nutrition-science-been-poisoned/2017-03-09T09:11:19-05:00http://www.cardiobrief.org/2017/03/14/for-scott-gottlieb-business-trumps-health/2017-03-30T10:00:27-04:00http://www.cardiobrief.org/2017/03/14/scott-gottliebs-sham-ideology-rejects-clinical-trials/2017-03-30T09:56:38-04:00http://www.cardiobrief.org/2017/03/17/fourier-shows-new-cholesterol-drugs-work-but-are-they-worth-it/2017-03-17T10:49:28-04:00http://www.cardiobrief.org/2017/03/17/novel-drug-delivers-long-term-cholesterol-reduction/2017-03-17T17:22:15-04:00http://www.cardiobrief.org/2017/03/18/ebbinghaus-study-may-help-refute-doctor-google/2017-03-18T15:58:42-04:00http://www.cardiobrief.org/2017/03/19/another-hdl-therapy-crashes-and-burns/2017-03-19T08:18:20-04:00http://www.cardiobrief.org/2017/03/21/tv-ads-pushed-inappropriate-use-of-testosterone/2017-03-21T11:20:41-04:00http://www.cardiobrief.org/2017/03/24/controversial-pharma-ceo-to-chair-aha-charity-ball/2017-03-24T16:10:56-04:00http://www.cardiobrief.org/2017/03/29/interventional-cardiologists-face-major-obstruction-in-treatment-of-total-blockages/2017-03-29T10:07:56-04:00http://www.cardiobrief.org/2017/03/31/more-bad-news-for-the-once-promising-bioresorbable-stent/2017-03-31T19:23:47-04:00http://www.cardiobrief.org/2017/04/05/pendulum-swings-further-away-from-vitamin-d-supplements/2017-04-06T08:39:30-04:00http://www.cardiobrief.org/2017/04/06/abbott-pulls-troubled-absorb-stent-from-european-market/2017-04-06T10:15:29-04:00http://www.cardiobrief.org/2017/04/09/can-sprint-be-used-to-inform-hypertension-treatment/2017-04-17T16:44:11-04:00http://www.cardiobrief.org/2017/04/12/ularitide-still-a-bust-after-true-ahf-peer-review/2017-04-12T16:54:09-04:00http://www.cardiobrief.org/2017/04/17/single-blood-test-rapidly-rules-out-mi-in-chest-pain/2017-04-18T12:51:51-04:00http://www.cardiobrief.org/2017/04/18/concerns-over-new-cardiac-blood-test-spark-intense-twitter-discussion/2017-04-18T13:37:08-04:00http://www.cardiobrief.org/2017/04/20/principal-investigator-defends-sprint-against-critics/2017-04-20T15:26:40-04:00http://www.cardiobrief.org/2017/04/26/serious-questions-raised-about-integrity-of-international-trials/2017-04-29T15:51:45-04:00http://www.cardiobrief.org/2017/04/29/as-another-trial-goes-bust-investigators-call-for-major-changes-in-international-trials/2017-04-30T20:21:02-04:00http://www.cardiobrief.org/2017/05/02/rigorous-study-debunks-alarms-that-statins-cause-muscle-problems/2017-05-04T12:53:47-04:00http://www.cardiobrief.org/2017/05/05/another-acute-heart-failure-drug-fails-in-large-clinical-trial/2017-05-05T10:18:25-04:00http://www.cardiobrief.org/2017/05/11/recent-blow-ups-spark-call-for-overhaul-of-clinical-trials/2017-05-14T23:48:57-04:00http://www.cardiobrief.org/2017/05/15/study-fuels-debate-over-when-to-start-cholesterol-screening/2017-05-15T15:33:46-04:00http://www.cardiobrief.org/2017/05/17/a-conversation-about-heart-failure-with-milton-packer-and-richard-lehman/2017-05-17T15:38:06-04:00http://www.cardiobrief.org/2017/05/17/end-of-the-road-for-cetp-inhibitors/2017-05-17T18:38:23-04:00http://www.cardiobrief.org/2017/05/18/dissecting-the-press-release-for-a-failed-stem-cell-trial/2017-05-18T18:48:37-04:00http://www.cardiobrief.org/2017/05/23/should-everyone-with-heart-failure-get-aggressive-treatment/2017-05-23T10:49:28-04:00http://www.cardiobrief.org/2017/05/24/two-nejm-papers-spotlight-promising-but-early-new-cardio-drugs/2017-05-24T17:21:53-04:00http://www.cardiobrief.org/2017/05/30/last-beats-of-the-failing-heart-two-views/2017-05-29T22:48:32-04:00http://www.cardiobrief.org/2017/05/31/new-review-supports-aggressive-bp-targets/2017-05-31T16:59:21-04:00http://www.cardiobrief.org/2017/06/01/study-finds-alarming-increase-in-us-bicycle-accidents/2017-06-01T18:26:12-04:00http://www.cardiobrief.org/2017/06/05/the-unintended-consequences-of-bicycle-helmets/2017-06-05T15:26:16-04:00http://www.cardiobrief.org/2017/06/07/new-stroke-prevention-device-may-not-prevent-strokes/2017-06-07T12:18:21-04:00http://www.cardiobrief.org/2017/06/12/trustee-for-zombie-lab-sues-thousands-of-doctors-and-dozens-of-nonprofits/2017-06-12T08:46:35-04:00http://www.cardiobrief.org/2017/06/12/review-lends-modest-support-to-chinese-traditional-medicine-for-cv-disease/2017-06-12T10:31:41-04:00http://www.cardiobrief.org/2017/06/14/serious-bleeding-risk-with-aspirin-soars-with-age/2017-06-14T10:18:11-04:00http://www.cardiobrief.org/2017/06/16/guest-post-vegetable-oils-francis-bacon-bing-crosby-and-the-american-heart-association/2017-06-21T15:37:24-04:00http://www.cardiobrief.org/2017/06/21/my-beef-with-the-ahas-saturated-fat-recommendations/2017-06-21T11:02:05-04:00http://www.cardiobrief.org/2017/06/23/no-one-knows-whats-actually-in-red-yeast-rice-supplements/2017-06-23T08:31:24-04:00http://www.cardiobrief.org/2017/06/26/does-whole-genome-sequencing-have-a-role-in-primary-care/2017-06-26T17:38:03-04:00http://www.cardiobrief.org/2017/06/27/merck-reveals-positive-findings-for-its-cetp-inhibitor/2017-06-27T10:05:00-04:00http://www.cardiobrief.org/2017/07/03/labscam-rogue-laboratory-testing-at-center-of-addiction-treatment-scandal/2017-07-03T16:38:09-04:00http://www.cardiobrief.org/2017/07/05/sudden-death-declining-in-heart-failure/2017-07-05T14:21:25-04:00http://www.cardiobrief.org/2017/07/10/new-studies-reassure-on-coffee-safety-suggest-survival-bump/2017-07-10T14:54:23-04:00http://www.cardiobrief.org/2017/07/11/questions-raised-about-trumps-new-cdc-boss/2017-07-11T16:42:16-04:00http://www.cardiobrief.org/2017/07/13/coronary-artery-calcium-rises-with-intense-exercise/2017-07-13T17:52:34-04:00http://www.cardiobrief.org/2017/07/17/aggressive-bp-targets-will-hike-falling-risk-in-older-patients/2017-07-17T11:52:12-04:00http://www.cardiobrief.org/2017/07/20/study-estimates-benefits-of-broad-primary-prevention-strategies-with-statins/2017-07-20T12:29:06-04:00http://www.cardiobrief.org/2017/07/21/forthcoming-expert-guideline-may-upgrade-pcsk9-inhibitors/2017-07-21T20:28:19-04:00http://www.cardiobrief.org/2017/07/24/potential-benefits-and-dangers-of-new-troponin-tests/2017-07-24T15:33:05-04:00http://www.cardiobrief.org/2017/07/24/nissen-calls-statin-denialism-a-deadly-internet-driven-cult/2017-07-24T15:54:50-04:00http://www.cardiobrief.org/2017/07/30/how-statins-make-some-people-crazy/2017-07-31T12:57:16-04:00http://www.cardiobrief.org/2017/08/04/ethical-questions-raised-about-nih-blood-transfusion-trial/2017-08-04T10:15:35-04:00http://www.cardiobrief.org/2017/08/08/pharma-phantasy-the-30-billion-pcsk9-inhibitor-market/2017-08-08T12:19:48-04:00http://www.cardiobrief.org/2017/08/10/generic-atenolol-in-short-supply/2017-08-10T09:05:42-04:00http://www.cardiobrief.org/2017/08/14/renal-denervation-back-from-the-dead-or-deja-vu-all-over-again/2017-08-14T13:15:37-04:00http://www.cardiobrief.org/2017/08/16/off-pump-cabg-raises-long-term-mortality-risk/2017-08-18T01:04:41-04:00http://www.cardiobrief.org/2017/08/17/big-mismatch-in-risk-perception-between-heart-failure-patients-and-their-physicians/2017-08-17T12:02:54-04:00http://www.cardiobrief.org/2017/08/23/new-economic-analyses-fail-to-make-case-for-pcsk9-inhibitors/2017-08-23T16:32:45-04:00http://www.cardiobrief.org/2017/08/27/cantos-validates-role-of-inflammation-in-heart-disease/2017-08-27T12:01:09-04:00http://www.cardiobrief.org/2017/08/28/renal-denervation-resurrected-with-modest-bp-reduction/2017-08-28T05:11:29-04:00http://www.cardiobrief.org/2017/08/29/merck-reveals-a-slightly-positive-cetp-inhibitor-trial/2017-08-29T04:16:22-04:00http://www.cardiobrief.org/2017/08/29/huge-diet-study-questions-conventional-wisdom-about-carbs-and-fats/2017-08-29T03:38:24-04:00http://www.cardiobrief.org/2017/08/29/sprint-substudy-detects-mortality-signal/2017-08-29T08:00:44-04:00http://www.cardiobrief.org/2017/09/07/cardiology-is-dead-long-live-public-health/2017-09-08T20:06:11-04:00http://www.cardiobrief.org/2017/09/11/julio-palmaz-really-doesnt-want-you-to-read-this-story/2026-04-08T11:16:28-04:00http://www.cardiobrief.org/2017/09/14/cardiac-stem-cell-therapies-may-get-boost-from-new-fda/2017-09-14T11:28:18-04:00http://www.cardiobrief.org/2017/09/18/what-if-pci-is-just-a-sham/2017-09-18T13:43:25-04:00http://www.cardiobrief.org/2017/09/20/barely-half-of-postmarket-studies-completed-after-5-years/2017-09-20T15:34:18-04:00http://www.cardiobrief.org/2017/09/21/benefits-of-physical-activity-seen-worldwide/2017-09-21T18:15:50-04:00http://www.cardiobrief.org/2017/09/25/stopping-aspirin-hikes-cv-risk/2017-09-25T15:50:59-04:00http://www.cardiobrief.org/2017/09/26/genotyping-reduces-adverse-events-with-warfarin/2017-09-26T11:13:54-04:00http://www.cardiobrief.org/2017/09/28/fdas-gottlieb-preparing-to-lower-the-bar-to-approval/2017-09-28T18:23:24-04:00http://www.cardiobrief.org/2017/10/04/some-doctors-reluctant-to-deactivate-lvads/2017-10-04T10:15:32-04:00http://www.cardiobrief.org/2017/10/06/upcoming-us-guideline-will-likely-set-13080-as-new-blood-pressure-target/2017-10-06T10:14:15-04:00http://www.cardiobrief.org/2017/10/10/side-effects-in-drug-ads-dont-add-up/2017-10-10T14:58:53-04:00http://www.cardiobrief.org/2017/10/11/merck-drops-development-of-once-promising-cetp-inhibitor/2017-10-11T20:28:11-04:00http://www.cardiobrief.org/2017/10/15/why-do-doctors-still-rely-on-ldl-instead-of-non-hdl-cholesterol/2017-10-15T17:18:08-04:00http://www.cardiobrief.org/2017/10/17/new-anticoagulants-not-linked-to-excess-bleeding-rates/2017-10-17T15:01:51-04:00http://www.cardiobrief.org/2017/10/19/imaging-studies-offer-new-insights-into-inflammation-in-cv-disease/2017-10-19T09:11:52-04:00http://www.cardiobrief.org/2017/10/23/blacks-face-higher-mortality-from-heart-disease-stroke/2017-10-23T11:22:07-04:00http://www.cardiobrief.org/2017/10/24/guest-post-future-cardiologists-lack-vision/2017-10-24T11:03:15-04:00http://www.cardiobrief.org/2017/10/27/new-and-improved-ldl-lab-numbers/2017-10-27T16:43:59-04:00http://www.cardiobrief.org/2017/11/02/small-trial-raises-big-concerns-that-pci-in-stable-angina-is-just-a-placebo/2017-11-02T11:06:15-04:00http://www.cardiobrief.org/2017/11/02/diving-deep-into-the-orbita-trial/2017-11-02T11:06:18-04:00http://www.cardiobrief.org/2017/11/03/the-story-behind-the-ny-times-orbita-anecdote/2017-11-03T20:01:40-04:00http://www.cardiobrief.org/2017/11/08/orbita-trial-puts-interventional-cardiologists-on-the-defensive/2017-11-08T18:00:04-05:00http://www.cardiobrief.org/2017/11/13/cantos-substudy-supports-major-role-of-inflammation/2017-11-12T23:53:23-05:00http://www.cardiobrief.org/2017/11/13/new-blood-pressure-guideline-sets-lower-13080-threshold/2017-11-13T15:33:55-05:00http://www.cardiobrief.org/2017/11/13/aha-president-suffers-a-heart-attack-monday-morning/2017-11-13T17:43:51-05:00http://www.cardiobrief.org/2017/11/14/the-survey-says-bp-measurement-in-sprint-was-all-over-the-place/2017-11-14T15:51:57-05:00http://www.cardiobrief.org/2017/11/15/the-once-and-future-catastrophic-cost-of-mi-stroke/2017-11-15T02:02:12-05:00http://www.cardiobrief.org/2017/11/22/why-was-orbita-mia-at-the-aha/2017-11-22T14:27:49-05:00http://www.cardiobrief.org/2017/11/27/no-benefit-found-for-pfo-closure-in-migraine/2017-11-27T19:08:36-05:00http://www.cardiobrief.org/2017/11/30/fda-approves-ecg-band-for-apple-watch/2017-11-30T19:15:47-05:00http://www.cardiobrief.org/2017/12/05/after-slow-start-entresto-is-poised-for-takeoff/2017-12-05T17:03:46-05:00http://www.cardiobrief.org/2017/12/06/clinical-trials-you-cant-always-get-what-you-want/2017-12-06T16:37:11-05:00http://www.cardiobrief.org/2017/12/10/in-defense-of-orbita/2017-12-10T18:44:45-05:00http://www.cardiobrief.org/2017/12/11/will-orbita-change-clinical-practice-the-role-of-perverse-economic-incentives/2017-12-11T12:02:50-05:00http://www.cardiobrief.org/2017/12/12/guest-post-get-ready-for-a-tsunami-of-ecgs/2017-12-12T15:01:21-05:00http://www.cardiobrief.org/2017/12/18/ms-inappropriate-defends-the-status-quo/2017-12-30T11:15:28-05:00http://www.cardiobrief.org/2017/12/21/nuance-and-the-healthcare-apocalypse/2017-12-21T15:36:06-05:00http://www.cardiobrief.org/2018/01/02/more-mini-trials-and-fewer-mega-trials/2018-01-02T09:30:35-05:00http://www.cardiobrief.org/2018/02/11/the-hypertension-guideline-war-is-not-a-fake-war/2018-02-11T16:33:31-05:00http://www.cardiobrief.org/2018/02/08/statin-critic-accused-of-image-manipulation-in-earlier-research/2018-02-08T15:31:17-05:00http://www.cardiobrief.org/2018/02/15/moment-of-truth-for-struggling-and-expensive-cholesterol-drugs/2018-02-15T15:06:09-05:00http://www.cardiobrief.org/2018/02/20/low-carb-and-low-fat-diets-battle-to-a-draw/2018-02-20T13:25:37-05:00http://www.cardiobrief.org/2018/02/27/device-companies-fund-courses-for-doctors-in-training/2018-02-27T11:40:47-05:00http://www.cardiobrief.org/2018/03/07/esperion-releases-top-line-results-for-first-pivotal-phase-3-study/2018-03-06T22:14:42-05:00http://www.cardiobrief.org/2018/03/10/the-odyssey-trial-ends-well-but-is-it-enough/2018-03-10T09:09:54-05:00http://www.cardiobrief.org/2018/03/18/cardiology-world-erupts-into-controversy-over-change-in-major-clinical-trial/2018-03-30T13:22:10-04:00http://www.cardiobrief.org/2018/03/30/more-controversy-over-major-cardiology-clinical-trial/2018-03-30T13:23:18-04:00http://www.cardiobrief.org/2018/05/10/cabana-no-outcomes-benefit-in-first-big-trial-of-af-ablation/2018-05-10T16:44:57-04:00http://www.cardiobrief.org/2018/05/21/salt-war-opponents-unite-in-call-for-randomized-trial-in-prisons/2018-05-21T12:24:59-04:00http://www.cardiobrief.org/2018/05/17/american-heart-association-venture-capital-fund-sparks-criticism/2018-05-18T11:06:13-04:00http://www.cardiobrief.org/2018/05/21/nih-halts-large-cardiovascular-inflammation-reduction-cirt-trial/2018-05-21T17:39:57-04:00http://www.cardiobrief.org/2018/05/22/new-orbita-findings-may-offer-modest-symptomatic-pain-relief-to-interventional-cardiologists/2018-05-22T10:10:45-04:00http://www.cardiobrief.org/2018/06/04/outsiders-swoop-in-vowing-to-rescue-rural-hospitals-short-on-hope-and-money/2018-06-04T22:50:51-04:00http://www.cardiobrief.org/2018/06/21/on-cannibals-and-cardiologists/2018-06-21T15:38:22-04:00http://www.cardiobrief.org/2018/07/04/1-in-4-cardiovascular-patients-in-low-income-families-have-significant-financial-pain/2018-07-04T16:54:43-04:00http://www.cardiobrief.org/2018/07/10/if-you-look-for-atrial-fibrillation-you-will-find-atrial-fibrillation/2018-07-09T23:37:25-04:00http://www.cardiobrief.org/2018/07/24/warning-pirate-sites-are-now-kidnapping-doctors-booking-hotels-at-medical-meetings/2018-07-24T14:29:36-04:00http://www.cardiobrief.org/2018/07/26/no-a-big-nih-trial-did-not-show-that-lowering-blood-pressure-will-prevent-dementia/2018-07-26T15:28:55-04:00http://www.cardiobrief.org/2018/08/09/lancet-paper-adds-to-evidence-that-reducing-salt-to-very-low-levels-may-be-dangerous/2018-08-09T22:40:19-04:00http://www.cardiobrief.org/2018/08/30/what-happens-when-a-healthy-86-year-old-gets-atrial-fibrillation/2018-08-30T11:52:23-04:00http://www.cardiobrief.org/2018/09/06/right-wing-minority-rule/2018-09-06T15:40:50-04:00http://www.cardiobrief.org/2018/09/19/cardiovascular-research-foundations-blocks-press-access-to-tct2018-meeting/2018-09-20T17:53:16-04:00http://www.cardiobrief.org/2018/10/31/questions-raised-about-invokana-label-expansion-for-cv-risk-reduction/2018-10-31T23:09:56-04:00http://www.cardiobrief.org/2018/12/22/the-simple-truth-about-fake-medical-news/2018-12-22T11:14:54-05:00http://www.cardiobrief.org/2019/03/15/health-hype-alert-beware-the-apple-watch/2019-03-15T08:20:48-04:00http://www.cardiobrief.org/2019/11/13/what-can-we-learn-from-the-apple-heart-study/2019-11-13T18:16:09-05:00http://www.cardiobrief.org/2020/06/30/no-crispr-is-not-going-to-cure-heart-disease/2020-06-30T17:16:58-04:00http://www.cardiobrief.org/2020/07/17/news-about-cardiobrief-and-cvctcardiobrief/2020-07-17T10:49:51-04:00http://www.cardiobrief.org/2020/08/20/dont-confuse-the-art-and-science-of-medicine-pci-vs-cabg-for-left-main-disease/2020-08-20T11:56:47-04:00http://www.cardiobrief.org/2020/08/24/a-covid-19-cardiac-mri-study-what-went-wrong/2020-08-24T18:34:29-04:00http://www.cardiobrief.org/2020/09/16/the-decline-of-science-in-the-pandemic/2020-09-16T10:13:24-04:00http://www.cardiobrief.org/2020/10/29/cardiology-research-business-as-usual-during-the-pandemic/2020-10-29T12:33:14-04:00http://www.cardiobrief.org/2020/12/10/the-defense-of-science-in-the-age-of-fake-news/2020-12-10T13:09:55-05:00http://www.cardiobrief.org/2021/01/25/should-the-acc-have-a-live-meeting/2021-01-25T12:18:49-05:00http://www.cardiobrief.org/2021/09/06/skeptics-and-the-pandemic/2021-09-06T09:31:09-04:00http://www.cardiobrief.org/2026/01/11/feeding-red-meat-to-the-maha-lions/2026-01-11T02:55:07-05:00